picture
RJR-logo

About | BLOGS | Portfolio | Misc | Recommended | What's New | What's Hot

About | BLOGS | Portfolio | Misc | Recommended | What's New | What's Hot

icon

Bibliography Options Menu

icon
QUERY RUN:
20 Nov 2026 at 01:55
HITS:
104064
PAGE OPTIONS:
Hide Abstracts   |   Hide Additional Links
NOTE:
Long bibliographies are displayed in blocks of 100 citations at a time. At the end of each block there is an option to load the next block.

Bibliography on: Microbiome

RJR-3x

Robert J. Robbins is a biologist, an educator, a science administrator, a publisher, an information technologist, and an IT leader and manager who specializes in advancing biomedical knowledge and supporting education through the application of information technology. More About:  RJR | OUR TEAM | OUR SERVICES | THIS WEBSITE

RJR: Recommended Bibliography 20 Nov 2026 at 01:55 Created: 

Microbiome

It has long been known that every multicellular organism coexists with large prokaryotic ecosystems — microbiomes — that completely cover its surfaces, external and internal. Recent studies have shown that these associated microbiomes are not mere contamination, but instead have profound effects upon the function and fitness of the multicellular organism. We now know that all MCEs are actually functional composites, holobionts, composed of more prokaryotic cells than eukaryotic cells and expressing more prokaryotic genes than eukaryotic genes. A full understanding of the biology of "individual" eukaryotes will now depend on an understanding of their associated microbiomes.

Created with PubMed® Query: microbiome[tiab] NOT pmcbook NOT ispreviousversion

Citations The Papers (from PubMed®)

-->

RevDate: 2026-11-18
CmpDate: 2026-11-18

Zhao J, Li Y, Shahid M, et al (2026)

Moderate Phosphorus Application Reshapes Rhizosphere Microbial Ecology and Coordinates Host Metabolic Responses to Improve Sweet Potato Yield and Quality: A Multiomics System-Level Analysis.

Journal of agricultural and food chemistry, 74(45):35330-35354.

Sweet potato is an important food, feed, and industrial crop whose storage root development and quality depend on phosphorus (P) availability, yet plant-soil-microbe responses to P fertilization remain unclear. We integrated agronomic, metagenomic, transcriptomic, metabolomic, and WGCNA analyses comparing moderate P application (P110; 110 kg P2O5 ha-1) with no P (P0). P110 increased soil organic carbon by 45.03% and available potassium by 9.58%; organic/inorganic P declined, while available P remained unchanged. Rhizosphere shifts included higher Acidobacteriota, Basidiomycota, and fungal diversity. P-cycling genes pckA, gcd, and ppk were higher, indicating altered metagenomic potential for soil P turnover. P110 increased storage roots per plant by 20.31-27.83%, yield by 31.88-41.45%, and plant P accumulation by 134.01%. Multiomics-linked hub genes (ARR6, LRR4, LRR3, FKF1, TIC100) and pathways to root traits, yield, and quality. Moderate P coordinates rhizosphere microbial ecology with host transcriptional and metabolic responses, improving P-use, yield, and quality.

RevDate: 2026-11-18

Zhou M, Li W, Sun W, et al (2026)

Beyond growth: engineering the root microbiota to shape fruit flavor.

Letters in applied microbiology pii:9089866 [Epub ahead of print].

Rhizosphere microbiota are increasingly recognized as key biological regulators of host metabolism, contributing to plant growth, nutrient acquisition, and secondary metabolism. Yet, compared with their well-established roles in promoting growth and enhancing stress resistance, the functions of the microbiota in fruit flavor formation remain poorly understood. We first outline the metabolic basis of fruit flavor formation, focusing on the major VOC biosynthetic pathways derived from fatty acids, amino acids, and terpenoids. We then synthesize current evidence that rhizosphere microorganisms modulate flavor in tomato, strawberry, and pepper. By integrating current studies on microbial remodeling of host VOC synthetic pathways, we discuss the potential contributions of the microbiome to fruit flavor. This review provides an integrated overview of microbiota-driven flavor regulation and highlights the potential of rhizosphere microbiome engineering as a targeted strategy to improve fruit flavor.

RevDate: 2026-11-18

Callewaert C, Spacova I, Minnebo Y, et al (2026)

Bidirectional Interplay Between the Skin Microbiota and the Host: An EAACI Task Force Report.

Allergy [Epub ahead of print].

The skin microbiome is a diverse community of bacteria, fungi, archaea, and viruses colonizing the human skin and is thought to play an important role in skin health. Skin homeostasis and immunity are influenced by a dynamic interplay between the host immune system, the skin microbiome, and other host factors. Disruption of the skin microbiome well-functioning by environmental, lifestyle, and host-related factors can lead to dysbiosis, which has been associated to some pathological skin conditions, resulting in skin inflammation and an impaired barrier function. Building on the previous work from the EAACI Task Force that emphasized how environmental and lifestyle factors impact host resilience through the skin microbiome, the present review focuses on intrinsic host factors. We provide a comprehensive discussion on how the skin composition differs at different anatomical locations and is influenced by age, gender, hormones, immune system activity, and how the host "multi-omes" (genome, transcriptome, proteome, and metabolome) interact with the skin microbiome. Additionally, we review current strategies to modify skin microbiome functions, including the role of diseases and medication, as well as topical microbiome-targeting biotic and bacteriophage therapies. Overall, this review highlights current knowledge and key research gaps, offering insights to guide future investigations and therapeutic innovations in skin health.

RevDate: 2026-11-18

Liu F, Liu MY, Zeng ZQ, et al (2026)

Fungal lignocellulose-degradation potential is associated with bacterial metabolic dysbiosis in the human gut.

The ISME journal pii:9089884 [Epub ahead of print].

Fungi encode diverse carbohydrate-processing functions, yet the genomic basis of their lignocellulose-degradation potential and its relevance to the human gut remain poorly understood. Here, we experimentally assessed cellulase-, xylanase-, and laccase-associated activities across 762 environmentally derived fungal isolates and sequenced 170 representative strains, retaining 160 genomes for genome-phenotype analyses. By integrating functional annotations with orthogroup presence-absence variation and machine-learning models, we identified lignocellulose-degradation-associated genomic features that improved phenotype prediction beyond conventional annotation alone. We then applied this framework to 2,116 publicly available fungal genomes and 704 cultivated gut fungal genomes from a previously published collection to construct a non-redundant catalogue of lignocellulose-degradation-associated genes (LDAGs), comprising canonical degradative enzymes, annotated phenotype-associated features, and candidate orthogroups. Across fungal lineages, xylanase-associated potential was broadly distributed, cellulase-associated potential showed an intermediate pattern, whereas laccase-associated oxidative potential was concentrated in a more restricted subset of taxa. Analysis of approximately 1,500 publicly available human gut metagenomes identified disease-associated differences in LDAG profiles in atherosclerotic cardiovascular disease (ACVD), inflammatory bowel disease (IBD), and obesity. Under stringent read-remapping criteria, total LDAG abundance differences remained significant in ACVD and IBD but were attenuated in obesity, whereas compositional differences persisted across all three cohorts with modest effect sizes. These fungal genomic signatures covaried with bacterial taxa, including Escherichia coli, and pathways involved in central carbon and carbohydrate metabolism. Together, our findings establish a phenotype-informed genomic framework for resolving fungal lignocellulose-degradation potential and reveal its consistent association with disease-related bacterial and metabolic configurations in the human gut.

RevDate: 2026-11-18
CmpDate: 2026-11-18

da Luz PL, D Favarato (2026)

Gut Microbiota, Red Wine and Atherosclerosis.

Current atherosclerosis reports, 28(1):.

PURPOSE OF REVIEW: To review the relationships among gut microbiota, dietary patterns, red wine (RW) consumption, and atherosclerosis, with emphasis on microbiome-related metabolic pathways and their potential relevance to cardiovascular prevention.

RECENT FINDINGS: Recent evidence has expanded our understanding of the microbiome-metabolome interface in cardiometabolic disease. Dietary patterns can modify microbial diversity and metabolites involved in inflammation, glucose homeostasis, and cardiovascular risk. Recent studies also support associations between wine-related dietary exposures, gut microbiota composition, and circulating metabolites. In the Wine Flora Study, moderate RW consumption was associated with broad shifts in gut microbiota and plasma metabolomic profiles without modifying plasma trimethylamine N-oxide. The gut microbiota participates in multiple metabolic pathways relevant to cardiovascular health and atherosclerosis. Diet is an important determinant of microbiome composition, and RW polyphenols may influence microbial and metabolic profiles. Nevertheless, a healthy diet, regular physical activity, smoking avoidance, and weight control remain cornerstones of cardiovascular prevention.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Maidin MST, Hashim AM, Malek AZA, et al (2026)

Microbial Shifts in Metisa plana (Lepidoptera: Psychidae) Larvae Exposed to Bacillus thuringiensis and Flubendiamide.

Microbial ecology, 89(1):.

Microbial communities in the insect body, especially in the gut, are crucial for host development, health, and environmental adaptation. However, little is currently understood about how these communities react to anthropogenic stressors, particularly when pesticides are used. This study aims to investigate the independent and synergistic effects of the biopesticide, Bacillus thuringiensis MPOB Bt1 (MPOB Bt1) and the synthetic diamide insecticide, flubendiamide (Fbd) on the microbial community of the oil palm bagworm, Metisa plana larvae. Larvae were collected at zero (DAT0), one (DAT1), and three days (DAT3) post-treatment and analyzed for bacterial genus abundance and network responses using shotgun metagenomic-derived taxonomic profiling. Analysis of larval microbial community shifts showed that the combined MPOB Bt1-Fbd treatment resulted in a significant increase in microbial richness, with network density rising from 0.1354 at DAT0 to 0.2279 at DAT3 compared to the individual Fbd treatment. Pearson correlation analysis also showed that the combined MPOB Bt1-Fbd treatment was associated with the growth of the microbiome members that can co-occur with Bacillus. The positive co-occurrence patterns between Bacillus and the genera Enterobacter and Pseudomonas in the combined MPOB Bt1-Fbd treatment may reflect treatment-associated microbial shifts during dysbiosis, with their ecological and functional relevance requiring further investigation. This preliminary study provides insights into microbial community responses to the mixture of MPOB Bt1-Fbd compared to the individual treatments. Further functional analysis of the microbial community is needed to clarify the potential roles of these taxa in pathogenicity, treatment response, and pesticide tolerance in the development of M. plana control methods in the future.

RevDate: 2026-11-18

Ou R, Zhong XS, Yu C, et al (2026)

Epigenetic activation of BCL11B is associated with profibrotic cardiac remodeling induced by colitis-associated gut dysbiosis.

Basic research in cardiology [Epub ahead of print].

Inflammatory bowel disease (IBD) is associated with increased cardiovascular risk, but the mechanisms linking gut dysbiosis to cardiac pathology remain poorly defined. We investigated whether transplantation of a dysbiotic microbiome (DM) from colitic mice alters cardiac function and explored the underlying mechanisms. Germ-free mice were colonized with normal microbiomes from wild-type donors or DMs from Il10[-]/[-] mice. Cardiac function was assessed by echocardiography, and gut microbiota and cardiac transcriptomes were analyzed by 16 S rRNA- and bulk RNA-sequencing, respectively. Chronic colitis was induced by repeated dextran sodium sulfate (DSS) administration, with or without fecal microbiota transplantation (FMT) from healthy controls. Epigenetic mechanisms were investigated using chromatin immunoprecipitation and methylation-specific qPCR. DM transplantation impaired cardiac contractility and increased collagen deposition. Cardiac RNA-seq revealed extensive transcriptional remodeling, particularly in females, with enrichment in histone acetylation and immune signaling pathways. Nat8f7 and Tet1 were upregulated, accompanied by increased histone acetylation and reduced DNA methylation at the Bcl11b promoter, enhancing RNA polymerase II recruitment and Bcl11b transcription. NAT8F7 and TET1 additively increased Bcl11b transcription and P1NP production in C2C12 cells. Similar molecular changes occurred during DSS-induced colitis and were reversed by healthy FMT. BCL11B overexpression promoted myoblast proliferation and collagen production. In conclusion, DM promotes cardiac fibrosis through epigenetic activation of Bcl11b, revealing a novel gut-heart axis. Healthy FMT mitigates these effects, highlighting microbiome-targeted strategies for IBD-associated cardiovascular complications.

RevDate: 2026-11-18

Khan M, Pant B, AH Kabir (2026)

Variovorax paradoxus alleviates bicarbonate-induced Fe limitation in cotton by altering the root-associated microbiome.

Journal of plant physiology, 327:154919 pii:S0176-1617(26)00232-4 [Epub ahead of print].

Alkaline and calcareous soils can induce iron (Fe) limitation in plants, yet the responses of root-associated microbial communities to beneficial rhizobacteria under these conditions remain poorly understood in cotton. Here, we investigated the effects of Variovorax paradoxus on plant performance, Fe nutrition, and root-associated microbiome dynamics in cotton exposed to bicarbonate-induced Fe limitation. In this study, V. paradoxus inoculation under bicarbonate-induced Fe limitation significantly improved photosynthetic parameters, growth parameters, and tissue Fe status. V. paradoxus inoculation partially reduced Fe-deficiency-induced root ferric-chelate reductase activity without a significant increase in net rhizosphere CAS-reactive Fe-chelating activity. This response may reflect a reduced requirement for maximal Strategy I activation following improved plant Fe status. Despite improved plant health, V. paradoxus reduced root C levels, suggesting altered belowground carbon utilization associated with bacterial inoculation and stress conditions. Split-root experiments showed greater improvements in chlorophyll score and shoot growth following bilateral than unilateral inoculation, although the effects of increased inoculum dose and root exposure could not be distinguished. In autoclaved soil, V. paradoxus did not improve plant growth under Fe deficiency, suggesting a possible role for resident soil microorganisms. Although bacterial alpha diversity remained unchanged, V. paradoxus significantly altered bacterial community composition and enriched Cellvibrio together with the fungal taxa Funneliformis and Dominikia under Fe limitation. Exploratory network analysis identified Funneliformis and Serendipita as highly connected fungal taxa associated with V. paradoxus treatment under Fe limitation, while core microbiome and indicator species analyses identified additional candidate microbial partners, including Pseudomonas, Hydrogenophaga, Shinella, and Aquabispora. Spearman correlation analysis further associated Streptomyces with root Fe accumulation and biomass, while Epicoccum and Sordariales were positively associated with CAS-reactive Fe-chelating activity in cotton exposed to bicarbonate-induced Fe limitation and inoculated with V. paradoxus. These findings highlight the potential of V. paradoxus to improve cotton Fe nutrition under bicarbonate-induced Fe limitation and identify root-associated microbial taxa whose functional contributions require further validation.

RevDate: 2026-11-18

Zhang Z, Yao Y, T Lian (2026)

Melatonin and rhizosphere microbiomes evidence, mechanisms, and causal gaps.

Plant physiology and biochemistry : PPB, 241:111959 pii:S0981-9428(26)00945-9 [Epub ahead of print].

Melatonin is widely used to improve plant tolerance to drought, salinity, low temperature, and metal stress. Several studies also report changes in soil or root-associated microbial communities, but the processes responsible for these changes remain unclear. This review distinguishes exogenous melatonin treatment from endogenous phytomelatonin regulation and evaluates the evidence for changes in root physiology and root-zone chemistry, ecological filtering, community restructuring, colonization, and plant benefit. Current studies document changes in microbial composition, sometimes alongside changes in plant or soil chemistry. However, these observations do not establish directed recruitment or show that the altered microbiome contributes to stress tolerance. Defined microbial inoculants provide evidence of effects on host melatonin or stress responses, but whether melatonin-induced changes in natural microbial communities have similar effects remains unknown. We define the ecological terms needed to interpret these results and assess the evidence provided by each experimental design. Future studies should combine chemical and microbial measurements over time with chemotaxis and colonization assays, microbiome manipulation, metabolite addition, and rebuilding microbial communities with defined strains. These tests are needed to determine whether microbial changes contribute to the plant response to melatonin.

RevDate: 2026-11-18

Song X, Wu R, Zhang H, et al (2026)

Integrated multi-omics and molecular modeling analyses of indaziflam distribution, ecological risks, and biological responses in a water-sediment system.

Journal of hazardous materials, 520:144251 pii:S0304-3894(26)03232-2 [Epub ahead of print].

Indaziflam is an alkylazine herbicide that inhibits cellulose biosynthesis, yet its environmental safety remains poorly understood. Indaziflam concentrations decreased in water under static exposure but remained relatively constant under semi-static exposure, while its concentrations in sediment increased under both exposure conditions. It exhibited moderate acute toxicity to zebrafish, Daphnia magna, and Chironomus kiiensis. During the 28-day exposure at 0.1 and 0.5 mg/L, indaziflam induced oxidative stress, disrupted antioxidant and detoxification enzyme activities, and affected neurochemical responses in zebrafish. Sediment microbial richness and diversity were significantly reduced, with altered community composition. Integrated microbiome and metabolomic analyses showed increased relative abundances of Pontibacter, Lysobacter, and Flavisolibacter following indaziflam exposure, indicating that these genera responded to indaziflam exposure. Zebrafish transcriptomic and metabolomic analyses showed altered pathways related to energy and nucleotide metabolism, cellular homeostasis, and neuroactive ligand-receptor interactions, alongside differential expression of neuronal signaling and detoxification genes. Molecular docking based on AlphaFold2 models and molecular dynamics simulations predicted a stable association between UGT5G2 and indaziflam, identifying UGT5G2 as a candidate detoxification protein. Collectively, this study characterizes the distribution and biological effects of indaziflam in a water-sediment system and identifies UGT5G2 as a candidate detoxification protein, providing evidence for its environmental risk assessment.

RevDate: 2026-11-18

Araujo ASF, Costa RM, de Medeiros EV, et al (2026)

Beyond weed control: Herbicide-driven rhizosphere dysbiosis in tropical agriculture.

Microbiological research, 316:128834 pii:S0944-5013(26)00398-8 [Epub ahead of print].

Herbicides are essential for tropical agriculture, enabling effective weed control and sustaining the productivity of intensive cropping systems. However, their impacts extend beyond target weeds, influencing the rhizosphere microbial communities that support soil and plant health. Previous studies have focused on short-term toxicity or changes in bulk soil microbiota, often under temperate conditions. Consequently, the ecological processes governing rhizosphere microbiome responses to repeated herbicide exposure remain poorly understood, particularly in tropical systems. In this review, we propose a conceptual model in which herbicides act as ecological filters that may progressively drive the transition from rhizosphere eubiosis to dysbiosis in tropical agroecosystems. This perspective integrates plant-mediated effects, microbial community assembly, interaction networks, and ecosystem functions to explain how repeated herbicide exposure progressively changes rhizosphere resilience. We discuss how herbicide-induced changes in plant physiology and root exudation modify microbial recruitment and community assembly and reshape microbial interaction networks. We further examine how these changes affect candidate keystone taxa, network stability, nutrient cycling, and plant resilience. Building on this ecological perspective, we evaluate emerging strategies to restore rhizosphere eubiosis, including defined microbial communities, in situ microbiome manipulation, regenerative agricultural practices, and microbiome-conscious herbicide management. Finally, we identify critical research priorities, highlighting the need for long-term field experiments, multi-omics approaches, ecological network validation, and microbiome-aware herbicide risk assessment. By integrating ecological theory with rhizosphere microbiome research, this review provides insights into herbicide-driven dysbiosis and offers new perspectives for developing sustainable, microbiome-informed weed management strategies that enhance soil and plant health in tropical agriculture.

RevDate: 2026-11-18

Shergojry SA, MR Dar (2026)

Nutritional and rumen microbiome determinants of enteric methane emissions in sheep: a systematic review and meta-analysis.

Archives of animal nutrition [Epub ahead of print].

Enteric methane (CH4) production in sheep represents both a significant global greenhouse gas challenge and a metabolic energy inefficiency, with energy losses of 6-10% of gross energy intake. This systematic review and meta-analysis aimed to quantitatively synthesise evidence on the genetic, nutritional and rumen microbiome determinants of methane production and methane yield (methane emitted per unit of dry matter intake, g CH4 /kg DMI) in sheep, and to evaluate integrated strategies for mitigation, including their associated carbon and water footprints. A systematic literature search was conducted across PubMed, EMBASE, and Cochrane Library databases for peer-reviewed studies published between 2000 and 2024. Studies meeting pre-defined PICOS criteria (species: sheep; sample size ≥ 20; traits: methane production/yield; study designs: experimental and observational) were included. Data were extracted on methane emissions (g/day; g/kg dry matter intake [DMI]), dietary composition (including starch and water-soluble carbohydrate content, where reported), rumen microbial taxa and heritability estimates. Statistical synthesis employed a random-effects meta-analytic model, with heterogeneity quantified using I[2] statistics and publication bias assessed via funnel plots and Egger's regression test. A total of 67 studies encompassing approximately 12,500 animals from 14 countries were included. A pooled heritability estimate of h[2] = 0.19 (95% CI: 0.14-0.24; I[2] = 64%) indicated moderate genetic control of methane production. High-forage, low-tannin diets significantly elevated methane output relative to concentrate-based diets, which promoted propionate fermentation pathways and reduced methanogenesis. Rumen microbiome composition, particularly the relative abundance of Methanobrevibacter spp. was significantly associated with inter-animal variation in methane yield (r = 0.58; p < 0.001). Defaunation interventions reduced methane emissions by approximately 11%. Integration of rumen microbiome data into genomic prediction models substantially improved accuracy from 0.42 (genomic-only) to 0.61 (genomic + microbiome). Carbon footprint estimates across production systems ranged from 15.8 to 17.1 kg CO2-eq/kg mutton carcass weight, and water footprint estimates ranged from 140 to 210 m[3]/kg mutton, tracking the same production-intensity gradient. Methane emissions in sheep are governed by the complex interplay of host genetics, rumen microbiome architecture and dietary substrate availability. Integrated approaches combining precision nutrition with microbiome-informed genomic selection represent the most effective and feasible pathway to simultaneously enhance feed efficiency and reduce environmental impact in small ruminant production systems.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Wang K, Shu X, Zhang R, et al (2026)

The Positive and Negative Selective Pressures Driving Polylysogeny.

Environmental microbiology, 28(11):.

Prophages are widespread genetic elements dormant in bacterial genomes and fundamental to bacterial physiology, evolution, and ecosystem processes. Recent evidence reveals that lysogeny can generate benefits for both prophages and bacterial hosts, against other phages infection, host adaptation, and ecological process. Many bacteria harbour multiple prophages, yet most prior studies have emphasised single-prophage effects and have not fully captured the evolutionary and mechanistic complexity of polylysogeny. Here, we aim to elucidate the major evolutionary forces and mechanistic determinants underlying polylysogeny. Because the behaviour of individual prophages underlies the emergence of polylysogeny, we first focus on the lysogenic decision and the stable coexistence of multiple prophages within a single bacterial host. Moreover, interactions among multiple prophages, ranging from cooperation (e.g., shared induction pathway and mutual stabilisation) to antagonism (e.g., competition and interference), collectively define polylysogenic states and their stability. Understanding these dynamics provides a framework for interpreting prophage-driven bacterial evolution and for leveraging prophage biology in microbiome and microbial ecosystem research.

RevDate: 2026-11-18

Maccarrone G, Montaguti L, Bruno A, et al (2026)

Modulation of the endocannabinoid system through diet, physical activity and microbiome in the new era of multiple sclerosis.

Neurobiology of disease pii:S0969-9961(26)00433-X [Epub ahead of print].

Multiple sclerosis (MS) is a chronic immune-mediated disorder characterized by neuroinflammation, inflammatory synaptopathy, and progressive neurodegeneration. Increasing evidence identifies the endocannabinoid system (ECS) as a regulator of synaptic transmission, neuroinflammatory tone, and neuroplasticity; however, its translational relevance in people with MS remains incompletely established. Cannabinoid-based compounds have their most established clinical role in symptomatic treatment, particularly for residual symptoms within the spasticity-plus syndrome, whereas effects on excitotoxicity, microglial activation, and neuroinflammation are supported mainly by mechanistic and preclinical evidence. Lifestyle-related factors, including physical activity, diet, and gut microbiome composition, have been associated with ECS-related signaling changes in healthy individuals and experimental models, but direct evidence of ECS-mediated effects in MS remains limited. Physical activity can increase circulating levels of the endocannabinoid anandamide in healthy individuals, while dietary components may influence ECS-related pathways through polyunsaturated fatty acids and phytochemicals; however, direct ECS-mediated clinical effects of either intervention in MS have not been demonstrated. Experimental evidence also supports bidirectional interactions between the gut microbiome and the ECS, although their clinical relevance in MS remains uncertain. Overall, these findings support a biologically plausible, hypothesis-generating framework linking lifestyle factors and ECS-related pathways alongside disease modifying treatments, without demonstrating causal mediation or disease-modifying efficacy. This review integrates preclinical and clinical evidence to distinguish established symptomatic effects from biological plausibility and indirect associations, and highlights priorities for prospective validation and personalized multimodal MS management.

RevDate: 2026-11-18

Dong W, Zhang G, Xu Y, et al (2026)

Rural Environmental Improvement Reshapes the Airborne Microbiome and Reduces Pathogenic and Antibiotic Resistance Risks.

Environmental research pii:S0013-9351(26)02537-5 [Epub ahead of print].

Nationwide government-led Rural Environmental Improvement (REI) initiatives are being extensively implemented across China. However, it remains poorly understood how such improvements influence airborne microorganisms and the antibiotic resistome, both of which are closely linked to human health risks. Here, we employed a space-for-time substitution approach based on one-year continuous sampling, collecting 99 airborne samples from improved and unimproved villages for 16S rRNA amplicon and autumn-specific shotgun metagenomic sequencing. Our results indicated that REI restructured airborne microbial community composition, with greater impacts on abundant taxa than rare taxa. REI was further associated with reduced relative abundance of airborne potential pathogens, showing a tentative 14.0% reduction under good air quality conditions. Metagenomic analyses targeting autumn samples demonstrated a 34.6% decline in normalized ARG abundance. Furthermore, REI was associated with decreased mobility potential of ARGs and lower prevalence of ARG-carrying contigs (ACCs) carried by pathogenic bacteria. This study provides critical insights into how REI reshapes the atmospheric microbial communities and resistome profiles, highlighting its potential to mitigate atmospheric biological health risks. These findings provide microbial evidence to support health-oriented rural ecological management and sustainable development.

RevDate: 2026-11-18

Kothawade S, Padwal V, S Dhobale (2026)

Artificial Intelligence in Precision Nutrition: From Multi-Omics Integration to Personalized Dietary Interventions.

Clinical nutrition ESPEN pii:S2405-4577(26)02347-8 [Epub ahead of print].

Artificial intelligence (AI) is increasingly being investigated as a tool for precision nutrition because it can analyse heterogeneous dietary, clinical, physiological, behavioural, and molecular data. This narrative review critically examines how machine learning, deep learning, computer vision, natural language processing, explainable AI, continuous glucose monitoring, wearable technologies, and multi-omics approaches may support individualized nutritional assessment and decision-making. Particular attention is given to the distinction between predictive research, digital personalized nutrition, AI-enabled clinical interventions, and commercial nutrition platforms. Current evidence shows that personalized digital nutrition can improve selected dietary behaviours, while observational AI and multi-omics studies can predict substantial inter-individual variation in metabolic responses. Importantly, evidence that an AI-enabled intervention improves clinical outcomes is still limited and is concentrated in selected settings, including a multicentre randomized trial of an AI-based dietary management platform in adults with type 2 diabetes. Emerging technologies such as large language models, digital twins, federated learning, and adaptive algorithms remain promising but require prospective clinical validation. Major barriers include data quality, algorithmic bias, privacy, interoperability, model transparency, regulatory uncertainty, and limited external validation. Future research should prioritize pragmatic multicentre randomized trials, transparent reporting of model performance, independent validation, health-economic evaluation, and clinically meaningful outcomes. AI should therefore be considered an adjunct to evidence-based nutritional care rather than a replacement for professional clinical judgement. The review differs from technology-centred and methodology-focused reviews by explicitly linking AI modalities and multi-omics data with evidence maturity, clinical trial findings, implementation barriers, and the level of inference justified for each technology.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Chakraborty A, Chakravarti M, R Bhattacharya (2026)

Biofilm mediated immune modulation in cancer progression.

Progress in molecular biology and translational science, 225:147-183.

The role of bacteria in causing cancer has been emerging as an increasingly important yet complex factor in tumor formation and proliferation, predominantly through indirect mechanisms, including chronic inflammation, immune modulation, and metabolic genotoxicity. Although only a handful of bacteria have been reported to contribute to specific types of cancers, for example, Chlamydia pneumoniae in lung carcinoma and Streptococcus bovis in colon cancer, their association with tumors is not specific and relies predominantly on chronic inflammatory processes. Nevertheless, the mouth offers a distinct and fragile niche because of its rich and complex microflora, biofilms, and exposure to environmental carcinogens. Specifically, patients with Oral squamous cell carcinoma (OSCC) present with a high colonization rate for bacterial pathogens like Streptococcus anginosus, Prevotella melaninogenica, and Capnocytophaga gingivalis. The main mechanisms driving tumor growth include cytokine network promotion, inhibition of apoptosis and cell cycle control, and production of carcinogenic metabolites like acetaldehyde, which is formed by alcohol metabolism. Moreover, microbial nitrosation produces N-nitroso compounds that can induce DNA alterations and mutations. The complex relationship involving microbial dysbiosis, biofilm formation, and immune system activity is further complicated by poor oral health practices and periodontitis. Overall, while roles of bacteria in cancers like melanoma or lung carcinoma are variable and indirect, the mouth is a highly relevant example of carcinogenic processes involving the microbiome, making it an important target for future cancer research and treatment. These findings underscore the need for continued investigation into oral biofilm-immune interactions as a foundation for novel cancer prevention and treatment strategies.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Mondal T, Padhan J, K K M (2026)

Exploring infection-associated genomic signatures in Bacteroides fragilis through integrative genomics, metagenomics and AI-based biomarker discovery.

Progress in molecular biology and translational science, 225:315-344.

Understanding genomic and microbiome-related determinants of bacterial pathogenicity requires integrative analysis of microbial genomic variation and functional traits. Here, we studied Bacteroides fragilis using comparative genomics, metagenomic integration, and AI-based analysis. We analyzed 54 high-quality genomes for SNPs, antimicrobial resistance (AMR), virulence factors, and mobile genetic elements (MGEs). Over 1.18 million SNPs were reduced to 8191 core SNPs after recombination filtering, demonstrating the major role of homologous recombination in genomic diversity and phylogeny. The resistome remained highly conserved, dominated by β-lactamase (cepA) variants and tet(Q). Virulence analysis identified conserved immune-modulatory genes, proteolytic factors, and widespread Type VI secretion system components. MGEs analysis revealed abundant insertion sequences, limited integrons, and a conserved plasmid replicon. Integration of 137 gut metagenomes recovered high-quality MAGs carrying AMR genes, biofilm-associated traits, and bft, supporting a role for B. fragilis in microbiome-associated pathogenicity. AI integration prioritized cepA-29, tet(Q), repUS21-repApBI143, and Type VI secretion system-associated genes as an AMR/plasmid/virulence-enriched signature. Because supervised models used clustering-derived pseudo-labels, performance reflects internal separability rather than external predictive validation. Overall, recombination, functional conservation, and microbiome dynamics collectively shape the pathogenic potential of B. fragilis.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Jiang D, Jiang J, Zhang C, et al (2026)

Integrated flavoromics and metagenomics reveal microbe-driven flavor deterioration of maize quality variation during simulated transportation.

Food research international (Ottawa, Ont.), 246:121155.

Maize transported over long distances is exposed to dynamic temperature-humidity fluctuations that accelerate flavor deterioration, yet the microbial and metabolic mechanisms underlying off-flavor formation remain poorly understood. Here, we integrated flavoromics based on HS-SPME-GC-MS/MS and GC-IMS with metagenomic sequencing to track the coordinated evolution of physicochemical properties, volatile compounds, and the epiphytic microbiome during simulated 'North-to-South Grain Transportation' under low (15 °C, 50% RH), medium (25 °C, 60% RH), and high (35 °C, 70% RH) temperature-humidity regimes. Fatty acid value, electrical conductivity, and malondialdehyde increased significantly with stress intensity, indicating progressive membrane damage and lipid peroxidation. Among the 81 unique volatiles identified across the two platforms, lipid oxidation-derived aldehydes (hexanal, (E)-2-nonenal, nonanal) and specific esters (ethyl nonanoate, ethyl oleate) were the most discriminative markers, and high-temperature stress shifted the flavor profile from fresh and fruity to stale and rancid. Metagenomics revealed directional community shifts in which Pantoea proliferated at the mid stage, followed by dominance of lipolytic Mucorales fungi (Mucor, Lichtheimia) and Aspergillus under hot-humid conditions. Puteibacter correlated strongly with oxidized aldehydes, whereas Mucor and Rhizopus were associated with esterification-related genes, and functional annotation confirmed enrichment of fatty acid degradation and amino acid metabolism pathways. These findings delineate distinct microbial community states across transportation stress intensities and establish a putative mechanistic cascade from microbial succession through lipid hydrolysis and beta-oxidation to off-flavor formation, providing a theoretical basis for objective flavor evaluation and quality control in grain logistics.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Calvanese CM, Valentino V, Buzzanca D, et al (2026)

Development of a novel potentially psychobiotic, plant-based fermented product: evaluation of the impact on the gut microbiome in m-SHIME® model.

Food research international (Ottawa, Ont.), 246:121127.

Modulating the gut microbiome through diet could positively influence mental health, offering new perspectives for dietary approaches in the treatment and prevention of mental disorders. Many lactic acid bacteria (LAB) found in fermented food are major microbial producers of neuroactive compounds. Three LAB strains, Limosilactobacillus (Lmb.) fermentum TO24, Levilactobacillus (Lvb.) brevis TO10, and Lentilactobacillus (Llb.) diolivorans B92, previously isolated from fermented foods, were used to ferment a plant-based matrix to develop a plant-based yogurt-like (pYL) product. We demonstrated that the strains were able to produce neuroactive compounds during fermentation and that remained stable during refrigerated storage of the pYL. The pYL was administered daily for 11 days to a m-SHIME® model simulating the gut microbiome of a depressed patient. The abundance of the pYL strains Lvb. brevis and Lmb. fermentum increased during treatment in both the lumen and mucosa samples, with Lvb. brevis persisting after the washout phase. The pYL treatment significantly inhibited potentially pro-inflammatory taxa (Acidaminococcus intestini and Megasphaera massiliensis) in both compartments. Notably, the neuroactive potential was not limited to the introduced strains. A significant functional redundancy emerged, as commensal Metagenome-Assembled Genomes (MAGs) were associated with key functional hubs involved in GABA biosynthesis. These encouraging findings suggest that the pYL treatment can modulate and partially restore the dysbiotic gut microbiome in depressed patients. Gut microbiome modulation through fermented foods consumption may represent a viable therapeutic strategy for mitigating mental diseases.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Han HY, Oh Y, Song JY, et al (2026)

Integrated microbiological assessment of ready-to-eat soft-boiled eggs: commercial product characterization and microbiome-based source tracking within a processing plant.

Food research international (Ottawa, Ont.), 246:121173.

Commercial soft-boiled egg products represent a rapidly expanding ready-to-eat (RTE) product category in South Korea. Although microbial reduction is generally expected during the heating of boiled egg products, RTE soft-boiled eggs require a more careful microbiological assessment because the yolk remains partially liquid and the products are consumed without further cooking. In this product category, culture-based counts alone cannot fully explain potential concerns of bacterial levels. Microbiome profiling can further characterize bacterial community composition when culture-based counts are low or sporadic. This study integrated culture-based method with temperature correlation, 16S rRNA amplicon sequencing and microbial source tracking. In commercial soft-boiled egg products, Escherichia coli and Salmonella spp. were not detected; however, APC was significantly higher in offline than online products (p < 0.001), with sporadic outliers and showed no correlation with storage or product temperatures. Within the processing plant, high APC was observed on the raw material receiving floor, while subsequent egg-stage samples showed lower APC levels. However, a relatively high APC was again observed on the final product shells, suggesting possible post-process recontamination after the heating step. 16S rRNA profiling revealed four distinct microbial community patterns among commercial RTE soft-boiled egg products and showed that the final-product microbiome was not simply a residue of incoming egg microbiota but reflected water- and processing-environment-associated taxa (e.g., Cupriavidus, Sphingomonas, Stenotrophomonas). This product and process analysis suggests that microbiological control of RTE soft-boiled egg production should extend beyond final-product testing to include processing water, cooled egg surfaces, and related processing environments.

RevDate: 2026-11-18

Klomkliew P, Phutthawong K, Visedthorn S, et al (2026)

Machine learning-integrated full-length 16S rRNA gene profiling reveals early-life gut microbial signatures associated with subsequent infantile colic in Thai infants.

Bioscience trends [Epub ahead of print].

Infantile colic develops after the neonatal period, but neonatal gut microbial patterns preceding symptom onset remain unclear. We examined early-life gut microbiome associations with subsequent infantile colic and internally evaluated microbiome-only prediction alongside retrospective metadata-containing comparisons. Stool samples collected 0-4 days after birth from 209 Thai infants (119 healthy and 90 who later met Rome IV diagnostic criteria for infantile colic) were profiled by Oxford Nanopore full-length 16S ribosomal RNA (rRNA) gene sequencing. Analyses included diversity and composition assessments, covariate-adjusted MaAsLin3 models, repeated nested cross-validation, and exploratory conditional association networks. Infants who subsequently developed infantile colic had lower Chao1 richness than healthy infants (q = 8.7 × 10[-5]), although delivery mode and collection day explained more community variation than outcome status. After covariate adjustment, Enterococcus faecium presence was associated with subsequent colic (odds ratio, 4.23; q = 0.021). The fully nested model-development procedure yielded participant-level area under the receiver operating characteristic curve (AUROC) and area under the precision-recall curve (AUPRC) values of 0.773 and 0.740. In a secondary fixed-model comparison including feeding summarized through one month, a species-presence radial basis function support vector machine outperformed metadata alone (mean outer-fold AUROC/AUPRC, 0.780/0.764 vs. 0.539/0.484), while adding metadata produced only a small, uncertain improvement. Exploratory network analysis contextualized candidate taxa within group-specific conditional association modules. These findings support a focused early-life species-level pattern associated with subsequent infantile colic and prioritize candidate microbial features for external validation.

RevDate: 2026-11-18

Song H, MJ Lee (2026)

The role of the gut microbiome in stress responses of dogs: gut-brain axis and microbiome-targeted interventions.

The Journal of veterinary medical science [Epub ahead of print].

Stress poses a significant threat to canine welfare and adoptability, particularly in animal shelters where dogs are exposed to multiple environmental and social stressors. Growing evidence suggests that the gut-brain axis (GBA), a bidirectional communication network linking the gastrointestinal tract and the central nervous system, plays a critical role in regulating stress responses. This review summarizes the mechanisms through which the gut microbiome influences canine behavior and physiology via neural, endocrine, immune, and metabolic pathways. We further examine current evidence showing that acute and chronic stress can disrupt the canine gut microbiome, leading to reduced microbial diversity and shifts toward pro-inflammatory bacterial communities. In addition, we discuss microbiome-targeted interventions, including probiotics, prebiotics, dietary modulation, and fecal microbiota transplantation, as potential strategies for improving stress resilience and gastrointestinal health. Collectively, the available evidence suggests modulation of the gut microbiome may provide a practical, non-invasive approach to supporting stress management and psychological well-being in dogs. A better understanding of host-microbiome interactions may contribute to the development of evidence-based nutritional and microbial interventions to improve canine stress management and welfare.

RevDate: 2026-11-18

Seliger B, Niang DGM, Zaz G, et al (2026)

African Cancer Immunology and Infection Initiative (TACII): reframing cancer research in Africa through immunology, infection, and the microbiome.

Journal for immunotherapy of cancer, 14(11):.

Cancer burden is increasing rapidly in Africa, yet its biology in this context remains insufficiently understood. Global cancer research relies disproportionately on data from high-income populations, overlooking interactions among infection, immune modulation, host diversity and the microbiome that may shape cancer risk, progression and therapeutic response across the continent. Endemic oncogenic infections, chronic immune activation and diverse microbial ecologies are therefore not peripheral variables but central components of the African cancer context. These dimensions remain fragmented across disciplines and under-represented in contemporary immuno-oncology. Here, we argue for an integrated research framework and propose The African Cancer Immunology and Infection Initiative (TACII), an Africa-led network designed to coordinate multidisciplinary research, shared infrastructure, harmonized cohorts and capacity strengthening. By linking infection, immunity, the microbiome and host context across African populations, TACII aims to generate context-relevant biomarkers and mechanisms while producing insights of global relevance to cancer biology and immunotherapy.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Hu J, Y Zhang (2026)

Butyrate and the brain-gut axis in Parkinson's disease: From microbial metabolite to potential therapeutic target.

The Journal of international medical research, 54(11):3000605261504876.

Parkinson's disease is a progressive neurodegenerative disorder with substantial unmet therapeutic needs. This narrative review synthesizes current mechanistic and clinical evidence on the role of the gut microbiota-derived short-chain fatty acid butyrate in the brain-gut axis in Parkinson's disease. Mechanistically, experimental studies suggest that butyrate reinforces intestinal barrier integrity and modulates intestinal immune responses, with enteric glial and vagal pathways providing possible links to central neuroinflammation. Its effects on microglial inflammatory phenotypes and autophagic clearance of α-synuclein, including possible cholinergic mediation, require further validation. We critically evaluated the strengths and limitations of this evidence, discussed inconsistent findings across cohorts, and summarized clinical studies on butyrate-related interventions, including butyrate supplementation, dietary fiber, probiotics, and fecal microbiota transplantation. Although preclinical evidence is substantial and context dependent, clinical translation is constrained by small and heterogeneous human cohorts, unresolved butyrate bioavailability, optimal dose and route of administration, long-term safety concerns, variability of the gut microbiota, and the absence of randomized evidence establishing butyrate-specific disease modification. Microglial heterogeneity revealed by single-cell transcriptomic studies also challenges the classical M1/M2 framework. We conclude by proposing priorities for future research, including well-powered randomized trials, standardized butyrate and microbiome measurements, patient stratification, and single-cell investigations.

RevDate: 2026-11-18

Wen X, Wang F, Xiang L, et al (2026)

The plant microbiome: a shield against agrochemical phytotoxicity.

Trends in plant science pii:S1360-1385(26)00342-0 [Epub ahead of print].

Agrochemicals impose systemic phytotoxicity on the plant holobiont through pesticide residues, fertilizer-induced soil degradation (e.g., acidification and heavy metal accumulation), and agricultural film-derived pollutants such as micro- and nanoplastics and additives. This challenge is further compounded by climate change. Although the plant microbiome is increasingly recognized as crucial for plant health and productivity, its potential for mitigating agrochemical-induced phytotoxicity remains underexplored. This review summarizes how microbes alleviate phytotoxicity and proposes a roadmap for microbiome-based strategies, including plant-driven strain selection, synthetic community construction, engineered microbes, and advanced delivery systems. Challenges in field applications and climate adaptation are examined. We conclude that developing resilient plant-microbiome systems capable of mitigating agrochemical phytotoxicity in chemically complex and climate-variable environments will be critical for sustainable agriculture.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Tao B, Song D, Dong M, et al (2026)

Spatially resolved host and microbiota RNA profiling in the mouse gut using microDBiT.

Nature communications, 17(1):.

Hosts and their microbiomes coexist in a shared environment, engaging in dynamic interactions that are essential to maintaining health and modulating disease processes. To fully understand these interactions, spatially resolved and unbiased approaches are needed to map gene expression from both host and microbial cells within their native tissue context. Here, we present microDBiT, a spatial transcriptomic platform that enables simultaneous, high-resolution profiling of host and bacterial RNAs, including both mRNA and rRNA. Using microDBiT, we mapped the spatial distribution of host and microbial transcripts in the ileum and colon of germ-free mice, gnotobiotic mice colonized with a defined gut microbial community, and specific pathogen-free mice treated with dextran sulfate sodium (DSS) to induce colitis. We observed location-specific transcriptomic alterations in both host and bacterial cells in response to colonization and during inflammation. These results demonstrate the utility of microDBiT for dissecting host-microbiome interactions at high resolution and provide new insights into immune responses, spatial microbial localization, and microbiome-associated disease processes.

RevDate: 2026-11-18

Gaïa M, Guyet U, Ruscheweyh HJ, et al (2026)

Closest relatives of poxviruses prevail in human and animal guts worldwide.

Nature [Epub ahead of print].

Large and giant double-stranded DNA viruses substantially affect eukaryotic ecology and evolution[1-4]. They prevail in the environment but are rarely found in the digestive system of animals[5,6]. Here we present the discovery of a diversified group of DNA viruses with large linear genomes, dubbed egoviruses, that comprise a putative viral order most closely related to animal-infecting poxviruses. Egoviruses are found worldwide, almost exclusively in the digestive system of humans, livestock and wild animals. The most prevalent human-specific egovirus is spread across continents, demonstrating a long-term association between egoviruses and the human gut microbiome. Eukaryotic homologues of egovirus core genes suggest that these viruses primarily infect Trichostomatia (ciliates), which assist ruminant digestive processes[7], and Parabasalia (Metamonada), which influence animal immunity and gut microbiome ecology[8]. Egoviruses also contributed to the genetic makeup of polintons, endogenous viruses that proliferated in genomes of Trichomonas vaginalis[9] and its close Parabasalia relatives. Unlike poxviruses that form brick-shaped virions, egoviruses are predicted to form multilayered icosahedral capsids resembling those of asfuviruses and probably representing the ancestral virion structure. Egoviruses are the only known clade of double-stranded DNA viruses of eukaryotes prevailing in the animal digestive system. Phylogenomic analysis suggests an evolutionary scenario whereby egovirus-like ancestors of poxviruses infected anaerobic unicellular eukaryotes inside the gut of ancestral animals, before transitioning to animal cell infection, which was accompanied by the virion metamorphosis.

RevDate: 2026-11-18

Dance A (2026)

Microbiome home tests are taking off. Can they be trusted?.

Nature, 659(8141):576-579.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Lapka H, Poniatowska-Rynkiewicz P, A Zmienko (2026)

Adaptive sampling: information-guided selection for targeted long-read sequencing and epigenetic studies.

Functional & integrative genomics, 26(1):.

Adaptive sampling (AS) is a unique feature of nanopore sequencing that enables real-time enrichment or depletion of target molecules during the sequencing run based on their initial sequence information. AS provides a flexible and scalable alternative to conventional capture- and amplification-based approaches, while preserving long reads and the ability to detect epigenetic modifications of native DNA/RNA molecules. In this review, we summarize the principles of AS-based sequencing, explain the enrichment- and depletion-mode strategies and discuss factors affecting its performance. We further highlight the growing body of studies demonstrating the utility of AS across a diverse range of applications, such as metagenomic and microbiome research, structural variant characterization and discovery, studying repeat expansion disorders, integrated genetic and epigenetic profiling or transcriptome analysis. In these and other contexts, AS enables efficient allocation of sequencing capacity toward biologically relevant molecules, while accelerating data generation, which also makes it applicable to rapid molecular diagnostics and real-time genomic analyses in clinical practice. As nanopore sequencing continues to mature and become a standard analysis approach in many laboratories, AS is likely to evolve from a specialized enrichment strategy into a routine component of genomic, epigenomic, and transcriptomic workflows.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Ma MY, YZ Gao (2027)

AI Analysis of Symbiotic Microorganisms and Personalized Diagnosis and Treatment.

Methods in molecular biology (Clifton, N.J.), 3103:187-200.

The intervention of artificial intelligence technology has brought revolutionary breakthroughs in microbiome research. Convolutional neural network and recurrent neural network based on deep learning can automatically extract high-order features in the data and capture early warning signals of diseases in the dynamic changes of intestinal microbiota. Random forest and gradient boosting algorithms accurately predict individual metabolic response to treatment through an ensemble learning strategy. These technological innovations are reshaping the medical research paradigm and pushing microbiome from basic research to clinical application. In the future, precise diagnosis and treatment based on individual microbiome characteristics may become a reality. From customized cancer immunotherapy to personalized nutritional intervention, AI is leading medicine into a new era of precision medicine.

RevDate: 2026-11-18
CmpDate: 2026-11-19

Gao Z, Song Q, Yin W, et al (2026)

Herbaceous intercropping reshapes soil microbial communities and induces transcriptomic responses in Morchella.

BMC ecology and evolution, 26(1):.

BACKGROUND: Morchella cultivation faces challenges from continuous cropping obstacles, which are often linked to soil degradation and microbial community shifts. Intercropping has emerged as a potential strategy to mitigate these constraints, yet the ecological mechanisms underlying herbaceous companion plant effects on Morchella remain poorly understood. This study investigated how intercropping with two functionally distinct herbaceous species-Poa pratensis and Vicia sativa-affects Morchella growth, soil microbial assembly, and Morchella transcriptional responses.

METHODS: Three cultivation treatments were established: Morchella monoculture (CK), intercropping with P. pratensis (B), and intercropping with V. sativa (P). Soil physicochemical properties, microbial community composition (16 S rRNA and ITS amplicon sequencing), and Morchella fruiting body transcriptomes (RNA-seq) were analyzed.

RESULTS: Intercropping reduced Morchella yield by 23.7% (P treatment) to 36.9% (B treatment) compared with monoculture, yet significantly increased soil available potassium and promoted companion plant growth. Microbial community analysis revealed that intercropping decreased the relative abundance of Ascomycota, particularly Morchella itself (reduced to approximately one-quarter of control levels), while increasing fungal α-diversity and enriching taxa such as Mortierella and Rhizopus. Bacterial communities also shifted, with Pseudomonas abundance increasing 3.3-fold (B) and 3.8-fold (P). Transcriptomic analysis identified 572 upregulated DEGs in the B treatment and 1,090 in the P treatment. Commonly upregulated DEGs were enriched in GO terms related to monocarboxylic acid metabolism, iron ion transport, and carbohydrate binding, and in KEGG pathways including fructose and mannose metabolism and nitrogen metabolism. Treatment-specific responses included enrichment of oxidation-reduction processes in B and symbiont attachment and biofilm formation in P. Continuously upregulated DEGs across the CK-B-P gradient were associated with chromatin assembly and metabolic pathway activation.

CONCLUSIONS: Herbaceous intercropping reconfigures the Morchella cultivation system by altering soil nutrient availability, reshaping microbial community structure, and inducing adaptive transcriptional responses in the fungus. Although intercropping enhanced soil ecological conditions and microbial functional diversity, it did not translate into yield improvement, suggesting ecological trade-offs between resource competition and environmental optimization. These findings provide a foundation for understanding host-microbe-plant interactions in fungal cultivation systems and highlight the need to balance ecological benefits with productivity outcomes.

RevDate: 2026-11-18
CmpDate: 2026-11-19

Hilal MG, Tang K, Shang Z, et al (2026)

The gut microbiota of Brandt's vole under varying population densities reveals contrasting patterns in the natural environment.

BMC microbiology, 26(1):.

BACKGROUND: The population density of rodents fluctuates due to intrinsic and extrinsic factors, inducing density-dependent effects on organisms and their habitats. The gut microbiota of herbivores plays a pivotal role in digestion, immunity, environmental adaptation, and host fitness. Crowding and host population density are considered among the driving factors that influence the gut microbiome of rodents. In laboratory settings, the gut microbiome of Brandt's voles exhibits distinct responses to density and crowding, which is a controlled environment and cannot mimic the natural system; however, its response in natural settings remains underexplored, which is more complex and shaped by biotic and abiotic interactions. Our study provides a comprehensive profiling of the (Lasiopodomys brandtii) gut microbiome at various population densities, under natural conditions, where diet and social structure fluctuate dynamically.

RESULTS: Across all densities, the dominant bacterial phyla were Firmicutes, Bacteroidota, Desulfobacterota, Campylobacterota, Actinobacteriota, and Patescibacteria. The Patescibacteria were significantly lower at medium (0.57% ± 0.117) and high densities (0.65% ± 0.423) than at low density (0.93% ± 0.339), whereas the Proteobacteria were higher at medium density (0.84% ± 0.518) than at low (0.43% ± 0.18) and high (0.54% ± 0.34) densities. Clostridia_vadinBB60 and F082 were reduced at high density relative to low and medium densities, and Lactobacillus abundance was lower at medium density compared with low and high densities. The microbial biomarkers at each density were (p < 0.05, LDA > 3): (Low; Bacilli, Helicobacter, Clostridiales_vadinBB60, F082, and Saccharimonadia), (Medium; Christensenellaceae), (High; Lactobacillus, Prevotella, and Lachnospiraceae). Alpha diversity was significantly lower at high density than at low and medium densities. At high density, Pielou's evenness, Shannon diversity index, observed richness, and Simpson's diversity were significantly lower than at low and medium densities (p < 0.05). Community structure differed significantly between low and high densities and between medium and high densities, but was similar between low and medium densities (p < 0.05). Bacterial predicted functional pathways varied significantly between low and medium densities and between high and medium densities, but showed no differences between low and high densities (p < 0.05). Density, AP, and pH were primary drivers of variance in microbial communities (p < 0.05). Mantel tests show that gut microbial diversity of voles is significantly correlated with density (r = 0.26, p = 0.0006) and water content (r = 0.19, p = 0.025), and microbial abundance is associated with soil water content (r = 0.26, p = 0.001) and aboveground biomass (AGB) (r = 0.24, p = 0.001). Density negatively affects microbial communities while positively affecting the soil physicochemical factors.

CONCLUSION: This study demonstrates that host population density serves as the primary driver of variation in gut microbiome in wild Brandt's voles. Soil properties and plant biomass act as secondary environmental filters. This work underscores the central role of host population dynamics in shaping the gut microbiome in natural systems, with potential implications for understanding how crowding stress influences host-microbe interactions in wild small mammals.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Wang Z, Qiu H, Qiao C, et al (2026)

The interactive regulatory effects of light exposure and bamboo fiber supplementation on growth performance, hormone levels, and gut microbiome composition in white-feathered broiler breeder chickens.

BMC veterinary research, 22(1):.

BACKGROUND: This study investigated the interactive effects of light intensity (4 Lux vs. 5 Lux) and bamboo fiber supplementation (0% vs. 1%) on growth performance, reproductive hormones, antioxidant status, laying performance, egg quality, and intestinal flora in Arbor Acres broiler breeders.

METHODS: A total of 32,000 Arbor Acres white broiler breeder hens at 49 days of age were randomly assigned to four treatment groups: 4 Lux basal diet, 5 Lux basal diet, 4 Lux + 1% bamboo fiber, and 5 Lux + 1% bamboo fiber, with eight replicates per group and 1,000 hens per replicate. The experimental period was 126 days.

RESULTS: Two-way ANOVA showed significant light × fiber interactions for estradiol, GSH-Px, MDA, and eggshell lightness L (P < 0.05). Light intensity alone affected FSH, UA, and eggshell color a* (P < 0.05). One-way ANOVA with post-hoc comparisons further showed that the 5 Lux + bamboo fiber group achieved the highest laying rate (45.40%) and significantly increased MT levels (54.61%). Compared to the 4 Lux group, the 5 Lux group showed increased FSH, E2, and GSH-Px activity, but decreased eggshell thickness (P < 0.05). Relative to the 5 Lux group, the 5 Lux + bamboo fiber group exhibited increased GSH, MDA, and GSH-Px, but decreased E2, ALB, and γ-GT (P < 0.05). This group also significantly reshaped the intestinal flora structure, increasing the Firmicutes/Bacteroidetes ratio from 1.91 to 19.34 and enriching beneficial bacteria such as Lactobacillus and Limosilactobacillus.

CONCLUSIONS: Combined 5 Lux lighting and 1% bamboo fiber improved laying rate and antioxidant status. These results suggest that light intensity and fiber intake can be managed together to support breeder performance.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Chen B, Xue E, Liu S, et al (2026)

Associations between gut microbiota-modulating diets and their components and metabolic syndrome.

Nutrition & metabolism, 23(1):.

BACKGROUND: Diet and gut microbiota alterations are key contributors to metabolic syndrome (MetS). As the Dietary Index for Gut Microbiota (DI-GM) captures diet-microbiome interplay, we examined the associations of DI-GM and its components with MetS.

METHODS: A total of 13,684 participants aged 20 years or older from the National Health and Nutrition Examination Survey 2007-2018 were included. DI-GM scores were calculated based on the mean dietary intake from two 24-h dietary recalls. Survey-weighted logistic regression, restricted cubic splines, and stratified analyses were used to assess associations, nonlinear dose-response patterns, and susceptible subgroups. Furthermore, weighted quantile sum (WQS) regression was employed to evaluate the collective impact of DI-GM components on MetS risk.

RESULTS: Higher DI-GM scores were associated with a lower odds of MetS, particularly for the unfavorable gut microbiota component (DI-GM: OR = 0.90, 95% CI: 0.86-0.93; unfavorable component: OR = 0.80, 95% CI: 0.76-0.85). Participants with scores ≥ 6 had markedly lower odds of MetS (OR = 0.63, 95% CI: 0.54-0.74) compared with those scoring 0-3 (P for trend < 0.001). Restricted cubic spline analyses indicated a linear association between DI-GM and MetS. The inverse association was more pronounced among individuals without diabetes (P for interaction < 0.05).

CONCLUSION: Higher DI-GM scores were associated with lower odds of MetS. These findings highlight the potential value of microbiota-focused dietary assessment for informing MetS-related dietary research and prevention strategies.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Lin S, Pang Y, Zhang H, et al (2026)

Tumor microbiome-based deep learning diagnostic and prognostic models for predicting immunotherapy efficacy and progression-free survival in lung cancer.

Journal of translational medicine, 24(1):.

BACKGROUND: Immune checkpoint inhibitors have become an important treatment for advanced lung cancer, but patient responses exhibit substantial interindividual variability. The tumor-associated microbiome is closely related to immunotherapy efficacy.

METHODS: Tumor tissue samples from lung cancer patients receiving immunotherapy were analyzed using 16 S-5R rRNA sequencing (Cohort 1). Two core models were constructed: a deep learning-based bacterial diagnostic model (BDM) incorporating hidden layers and a Squeeze-and-Excitation block to predict immunotherapy response status, and a Cox proportional hazards (CoxPH) prognostic model to predict progression-free survival (PFS). Furthermore, four core bacterial species were selected using SHAP values, and a probe-based multiplex qPCR detection system (BDM-mqPCR) was developed (Cohort 2).

RESULTS: The BDM achieved a sensitivity of 96.55% and 87.50%, specificity of 96.15% and 100.00%, and AUC of 0.989 and 1.000 in the training and validation set. The CoxPH model showed high concordance between predicted PFS curves and actual outcomes in both the training and validation sets, effectively distinguishing high-risk from low-risk patients, further providing the probability distribution of their PFS to help physicians decide whether to prepare subsequent treatment in advance or intensify monitoring. BDM-mqPCR constructed using the four SHAP-selected species achieved AUCs of 0.828 (training) and 0.869 (validation), which were lower than those of the BDM but significantly superior to Biomarker model, offering the advantages of rapidity, cost-effectiveness, and target specificity.

CONCLUSION: BDM model and the CoxPH model achieved a complete assessment from whether a response occurs to how long the response lasts, providing a microbiome-driven precision tool for individualized decision-making in lung cancer immunotherapy.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Li L, Yu W, Chang F, et al (2026)

Environmental heterogeneity overrides host phylogenetic distance in shaping the microbiome of Acropora corals.

Animal microbiome, 8(1):.

Coral ecosystems are among the most representative symbiosis systems, with profound scientific significance for understanding the relationships between host and their microbiome. Environmental filtering and host phylogeny play essential roles in maintaining the microbiome of coral holobionts, yet their relative contribution to community assembly remains unsettled. In this study, we analyzed the bacterial composition of 170 samples from 46 Acropora species across two geomorphologically contrasting reefs in the South China Sea, the steep-sloped Meiji Reef and the flat Beiwai Reef. Our results demonstrate that Acropora corals from the two reefs host specialized bacterial assemblages distinct from those in the surrounding seawater, which are primarily shaped by deterministic processes. Within Acropora genus, bacterial communities associated with hosts showed significant differences in taxonomic composition between the two reefs, and environmental drivers such as dissolved oxygen and primary production outweighed host phylogenetic signals in shaping bacterial community structure. Despite differences in microbial community composition, similar metabolic pathways were enriched in both reefs, representing core functional stability across environments. Co-occurrence network analysis further revealed that corals in these two reefs employed distinct topological strategies to achieve microbiome functional stability. These findings indicate that taxonomic flexibility combined with functional stability forms a stable yet adaptable strategy, allowing Acropora to adjust to diverse environmental conditions. Our study highlights the vital role of environmental-microbial synergy in coral resilience and offers a theoretical foundation for microbe-informed reef restoration amid rapid global change.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Martínez-López N, Pereiro P, Figueras A, et al (2026)

Evaluation of the turbot (Scophthalmus maximus) microbiome and host antiviral response to viral hemorrhagic septicemia virus (VHSV) after treatment with oxytetracycline.

Animal microbiome, 8(1):.

BACKGROUND: Aquaculture intensification has led to widespread antibiotic use to control disease outbreaks, but antibiotic-mediated disruption of the intestinal microbiota can have unintended consequences for host immunity and disease susceptibility. The microbiota is increasingly recognized as a key regulator of systemic immune response, yet the impact of antibiotic-induced dysbiosis on viral infections in fish remains poorly understood.

RESULTS: Here, we show that exposure to oxytetracycline (OTC), a commonly used antibiotic in aquaculture, significantly increases susceptibility to viral hemorrhagic septicemia virus (VHSV) infection in juvenile turbot (Scophthalmus maximus). Fish challenged with VHSV shortly after OTC treatment exhibited a modest but significant reduction in survival (10-13% across two independent trials). By contrast, infection at 30 days post-treatment resulted in survival rates comparable to untreated controls. To explore the mechanisms underlying this transient increase in viral susceptibility, we investigated gut microbiota composition, predicted microbial functional potential, host transcriptomic responses, and intestinal architecture following OTC exposure. OTC treatment induced a marked but transient intestinal dysbiosis, characterized at 24 h post-treatment by a drastic reduction of two key commensal bacterial families, Vibrionaceae and Marinobacteraceae. While alpha diversity remained largely unchanged, beta diversity and co-occurrence network analyses revealed pronounced microbial community restructuring, with reduced correlation structure and properties shortly after treatment, followed by partial recovery at 30 days, which may account for the absence of survival differences at the later infection time point. Functionally, OTC-induced dysbiosis was associated with shifts in the predicted microbial metabolic potential, including pathways related to lipid metabolism and glycan biosynthesis. Transcriptomic analyses of head kidney and intestine revealed that OTC altered the expression of key antiviral, antioxidant, and inflammatory genes, particularly in the intestine, where a strong upregulation of DNA replication and cell cycle-related genes suggested a direct effect of OTC on intestinal architecture, supported by histological analyses.

CONCLUSIONS: Together, these findings could suggest that OTC-induced microbiota disruption, combined with its potential toxic effect on the host, compromises intestinal immune homeostasis and transiently increases susceptibility to viral infection, highlighting the need for more judicious antibiotic use in aquaculture.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Marková K, Schmiedová L, Grymová V, et al (2026)

Captive parrot interspecific and intraspecific variation in gastrointestinal microbiota composition revealed by large-scale profiling.

Animal microbiome, 8(1):.

BACKGROUND: Parrots (Psittaciformes) are the most popular pet birds kept throughout the world. It is estimated that presently about half of the global parrot population lives in captivity. However, domestic parrots are susceptible to numerous health issues, with digestive and behavioural disorders being the most commonly reported. Such disorders can be linked to gastrointestinal tract (GIT) microbiota either directly or via gut-brain axis. Yet, the parrot GIT microbiota is largely unexplored, which limits the potential for therapeutic use of probiotics in veterinary practice. Here, we addressed the interspecific and intraspecific variation in parrot-associated bacterial diversity by assessing healthy captive parrots' GIT bacterial microbiota composition through 16 S rRNA profiling.

RESULTS: We analysed faecal and oral microbiota of 286 individuals from 66 parrot species. Faecal and oral microbiota differed in composition, with oral microbiota having significantly higher alpha diversity and lower interindividual variation. We did not find any core OTU or bacterial genus present in faecal or oral samples of all individuals or species studied. Yet, the genera Corynebacterium and Streptococcus were represented in over 90% of the oral samples. Lactobacillus was predominant in faeces (75% of the samples). Our results reveal high interspecific and intraspecific variation in both faecal and oral microbiota, with host species and owner identity being the most important factors influencing microbial composition and diversity. Individuals representing the same parrot species or genus shared similar microbiotas, but deeper phylogenetic lineages showed only low levels of phylosymbiosis. Similarities in the composition of the parrot oral microbiota were more strongly aligned with phylogeny than similarities observed in the faecal microbiota. Sampling date exerted minor yet significant effects on microbial composition, and sex had an additional effect in the oral microbiota.

CONCLUSIONS: This study provides presently the most comprehensive characterisation of the GIT microbiota composition and its variation in parrots. Comparing a wide range of healthy captive parrots, we uncover the main factors contributing to microbiome diversity. Our results offer a reference for further research aimed at investigation of the physiological effects of GIT bacteria and the development of novel veterinary therapeutics.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Schambach JY, Mascarenas MR, Butler S, et al (2026)

Accelerating anaerobic digestion of lignocellulosic digestate via chelator-mediated Fenton treatment and microbial community acclimatization.

Biotechnology for biofuels and bioproducts, 19(1):.

As a major byproduct of anaerobic digestion (AD), lignocellulosic digestate contains carbon-rich organic material that can be used as a soil amendment in agriculture or further valorized to maximize biomethane recovery-the focus of this research. We previously reported that chelator-mediated Fenton (CMF) treatment enhanced biomethane yield from lignocellulosic residues, with the extent of improvement varying based on the level of substrate oxidation and the microbial composition of the inoculum. The inoculum-dependent results suggested that acclimatizing the inoculum to CMF-treated digestate can further enhance AD by promoting the enrichment of a core microbial community. To test this hypothesis, we conducted four sequential AD runs under thermophilic conditions to examine how inoculum acclimatization affects the biodegradation of CMF-treated digestate with low or high oxidant dosages. CMF treatment alone yielded a four- to sixfold increase in methane production compared to untreated controls. Subsequent acclimatization further improved methane productivity by eliminating lag phases, maximizing methane production rates for both substrates, and significantly shortening the time to reach maximum biomethane potential (BMP). Digestate oxidized at the lower dosage exhibited an additional 20% increase in BMP following acclimatization, approaching methane yields previously observed only in highly oxidized digestates. These improvements coincided with microbial community restructuring, characterized by a decrease in alpha diversity and enrichment of microorganisms commonly associated with hydrolysis and acidogenesis. Microbiome acclimatization to CMF-treated digestates revealed a previously underappreciated adaptive response to chemically oxidized substrates, leading to improved anaerobic digestion kinetics and the potential to reduce oxidant usage while sustaining process performance.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Jeong T, Park W, Jang S, et al (2026)

Integrative multi-omics analysis of host genetics, rumen transcriptome and microbiome prioritizes candidate features associated with body weight in Hanwoo steers.

Animal microbiome, 8(1):.

Hanwoo (Korean cattle) is an indigenous breed of high economic value in Korea, where improving body weight (BW) remains a priority for both productivity and farm profitability. Because growth traits are shaped by multiple biological layers, including host genetics, rumen microbial ecology, and transcriptomic regulation, a single-omics perspective is often insufficient. To address this complexity, we applied an integrative multi-omics framework, DIABLO (Data Integration Analysis for Biomarker discovery using Latent cOmponents), combining genomic (42,091 SNPs), rumen transcriptomic (RNA-seq), and microbiome (16S rRNA) data from 58 steers. After adjusting BW for age, animals were classified into High- and Low-BW groups. Feature pre-selection yielded 100 discriminant SNPs, 161 large-effect candidate expression features, and 20 candidate microbial features showing nominal abundance differences between groups. Integration of these datasets highlighted exploratory SNP-gene-microbiome associations, including three SNPs, ARS-BFGL-NGS-104362, ARS-BFGL-NGS-43924 and ARS-BFGL-NGS-24293, that remained significantly associated with BW. These variants were linked to epithelial and metabolic genes such as FUT1, KRTDAP, and TCN1, which in turn showed strong correlations with Anaerobutyricum, a butyrate-producing genus identified as an exploratory microbial candidate. Taken together, these results suggest candidate host epithelial and rumen microbial axes associated with BW variation, rather than establishing causal mechanisms. By applying a supervised multi-omics integration strategy, this study identifies exploratory candidate multi-omics features associated with BW variation in Hanwoo steers. Because of the modest sample size and the supervised nature of the integration framework, the resulting signature should be interpreted as hypothesis-generating and requiring validation in larger independent cohorts.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Van Dingenen L, Segers C, Mysara M, et al (2026)

Dose-dependent microbiome, metabolome and lipidome shifts in a mouse model of colitis-associated colorectal cancer using azoxymethane and dextran sodium sulphate.

Animal microbiome, 8(1):.

BACKGROUND: Colorectal cancer (CRC) remains a major health burden, underscoring the need for continued research to improve screening methods and treatment outcomes. The colitis-associated azoxymethane (AOM) and dextran sodium sulphate (DSS) mouse model has proven valuable for CRC research, as it closely mimics human CRC development and captures the complex interactions between the gut microbiome and immune system. However, variations in AOM/DSS dosing reported in literature can influence baseline conditions, thereby affecting the outcome and interpretation of experimental and therapeutic interventions.

RESULTS: This study evaluated the impact of varying AOM and DSS doses on CRC development and the gut microbiome, metabolome and lipidome in mouse faeces (n = 29). Inflammation-driven CRC progression was more pronounced in mice treated with high-dose AOM (12.5 mg/kg) combined with high-dose DSS (2%) than in those receiving lower doses. Faecal 16S rRNA-based microbiome analysis revealed significant shifts in the high-dose AOM groups, which coincided with the highest tumour burden. Operational taxonomic units (OTUs) belonging to Prevotella, Turicibacter, Intestinimonas and Akkermansia muciniphila displayed patterns linked to inflammation and tumour progression, with distinct temporal abundance increases across AOM/DSS dosing groups. State-of-the-art, validated UHPLC-HRMS methodologies for faecal metabolomics and lipidomics fingerprinting (7951 features) and profiling (202 targets) identified imidazolepropionic acid, a microbe-derived metabolite, as a candidate biomarker associated with inflammation-driven CRC. In addition, mice with a high tumour burden presented elevated levels of lactic acid and γ-glutamylphenylalanine as well as decreased levels of fumaric acid, 6-deoxygalactose, glucosamine/mannosamine and L-threonine, all of which are associated with gut barrier dysfunction and inflammation. Furthermore, there was a decreased abundance of a short-chain acylcarnitine and both odd-chain and even-chain fatty acids, suggesting that altered energy metabolism may be associated with CRC progression. Multi-omics integration revealed a factor shaped by differential contributions from metabolites and lipids linked to Lachnospiraceae spp., with compounds like lactic acid, methylmalonic acid, linoleic acid and palmitoleic acid positively associated with inflammation and CRC, while hypoxanthine, nicotinic acid/2-picolinic acid, L-carnitine and deoxycarnitine, showed potential protective associations.

CONCLUSIONS: These findings highlight the complex interplay between gut inflammation, microbiome dynamics and metabolic reprogramming in CRC and suggest that AOM/DSS dosing substantially influences these interactions.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Hu Y, Zhuo Z, Wang Q, et al (2026)

Bamboo leaf flavonoids modulate the colonic host-microbiome interface in goat kids to enhance immune function.

Animal microbiome, 8(1):.

BACKGROUND: Bamboo leaf flavonoids (BLF) exhibit multiple nutritional and biological benefits for animals; however, the impact of these compounds on goat kids has not been fully elucidated. This research assessed the impacts of BLF on blood immunity, colonic metabolites, microbial composition, and barrier functions in goat kids.

RESULTS: A total of 64 goat kids (10 days old, initial body weight of 3.77 ± 0.60 kg) were randomly assigned to four dietary treatments: milk only (CON), milk supplemented with BLF at 30 mg/kg body weight (LBLF), milk supplemented with BLF at 60 mg/kg BW (MBLF), and milk supplemented with BLF at 120 mg/kg BW (HBLF). The findings indicated that BLF-treated groups had a significantly lower frequency of diarrhea over the 50-day experimental period compared to the CON group. Goat kids in the MBLF group exhibited significantly higher serum levels of the cytokines IL-2 and IL-4 compared to the CON group (P < 0.05), whereas no significant differences were detected in IL-6, IL-1β, or TNF-α levels (P > 0.05). Furthermore, the MBLF group showed elevated serum IgG levels (P < 0.05), while IgM and IgA levels remained unchanged relative to the CON group (P > 0.05). The MBLF group had a greater colon length than the CON, LBLF, and HBLF groups. Qualitative histological examination suggested a comparatively well-organized colonic morphology in the MBLF group. BLF supplementation significantly reshaped colonic metabolite profiles and increased the relative abundance of metabolites annotated to the KEGG flavone and flavonol biosynthesis pathway; these metabolic changes were associated with improved immune function and anti-inflammatory capacity in goat kids. Additionally, BLF supplementation altered the colonic microbial community structure and increased the relative abundance of dominant bacteria linked to a healthy intestinal tract. Meanwhile, the expression of junction-related genes-including ZO-1, claudin-2, claudin-1, and occludin-was significantly upregulated in the colon tissue.

CONCLUSIONS: In conclusion, these results demonstrate that BLF enhances intestinal health and immune function in goat kids. This protective effect may be mediated through alterations in gut metabolites, which subsequently promote the enrichment of beneficial microbes and modulate host immune responses.

RevDate: 2026-11-19

El-Beltagi HS, Hassan KM, Rezk AA, et al (2026)

Heavy Metal Uptake, Signalling, Detoxification and Environmental Adaptation in Plants: Mechanistic Insights and Emerging Mitigation Strategies.

Plant, cell & environment [Epub ahead of print].

Heavy metal contamination has emerged as a widespread environmental problem that threatens ecosystem functioning, biodiversity and plant performance across natural and managed ecosystems. Toxic elements, including cadmium (Cd), lead (Pb), nickel (Ni), zinc (Zn), aluminium (Al) and other potentially hazardous metals, can accumulate in plant tissues, disrupting growth, development, physiological processes and cellular homoeostasis while posing risks to ecological and human health through trophic transfer. Understanding the mechanisms underlying metal uptake, transport, sequestration and detoxification is therefore essential for increasing plant resilience in metal-stressed environments. This review synthesises current knowledge of plant responses to heavy metal stress, integrating physiological, biochemical, cellular, genetic and molecular mechanisms that contribute to tolerance and adaptation. Particular attention is given to the factors regulating metal accumulation and distribution within plants, including species and genotypic variation, soil physicochemical properties, rhizosphere processes, microbial associations and environmental conditions. This review also evaluates recent advances in strategies to mitigate heavy metal toxicity, including nutrient-based approaches, soil amendments, beneficial microorganisms, biostimulants, phytoremediation technologies, rhizosphere engineering and nanotechnology-assisted interventions. Emerging evidence indicates that plant responses to heavy metals are highly species-specific and strongly shaped by plant-microbe-soil interactions, emphasising the importance of integrated and context-dependent management approaches. Despite substantial progress, significant knowledge gaps remain regarding the regulation of metal partitioning, long-term adaptive responses, cross-tolerance mechanisms and the identification of critical thresholds for maintaining plant health under diverse environmental conditions. Future research integrating multiomics technologies, microbiome engineering, molecular breeding and precision remediation strategies will provide new opportunities to strengthen plant resilience and reduce the ecological risks associated with heavy metal contamination. By consolidating current advances and future directions, this review offers a comprehensive framework for understanding plant adaptation to heavy metal stress and for supporting sustainable ecosystem management in contaminated environments.

RevDate: 2026-11-19

Gupta AK, Liddy A, Saunte DML, et al (2026)

The Skin and Gut Microbiome in Hidradenitis Suppurativa.

Dermatology (Basel, Switzerland) pii:9099706 [Epub ahead of print].

BACKGROUND: Recent evidence indicates that both the bacterial composition of the skin and gut microbiota may contribute to the pathogenesis and progression of hidradenitis suppurativa (HS).

SUMMARY: Several studies have identified differences in the skin bacterial microbiota of patients with HS compared with individuals without HS, as well as between lesional and non-lesional skin among patients with HS. These differences include an increased abundance of anaerobic taxa such as Prevotella and Porphyromonas, alongside a reduction in commensal taxa such as Cutibacterium, which may contribute to chronic inflammation and biofilm formation. Comparative analyses of HS lesional versus non-lesional skin have also revealed enrichment of bacterial pathways related to cell growth, DNA replication, and mismatch repair, suggesting enhanced microbial proliferation within HS lesions. Emerging evidence further suggests the presence of bacterial gut dysbiosis in HS, with some studies reporting reduced microbial diversity and lower abundance of protective genera Ruminococcaceae and Lachnospiraceae families. Efforts to modulate the skin and gut microbiota in HS are underway, exploring approaches such as dietary modification, antibiotic usage, and probiotic supplementation.

KEY MESSAGES: The skin and gut microbiota may contribute to HS pathogenesis through alterations in microbial composition, microbial function, and interactions with systemic inflammation. However, current research remains fragmented, with small sample sizes, heterogeneous study designs, and a scarcity of robust interventional data. Further research is needed to clarify the role of microbiota in HS and determine whether microbiome-targeted interventions can improve disease outcomes.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Li Z, Chen Y, Sun Y, et al (2026)

In harmony? A scoping review of methods to combine multiple 16S amplicon datasets.

AJE advances : research in epidemiology, 2(3):uuag029.

Robust evidence on relationships between the human microbiome and health is critical for understanding and improving the human condition. However, there is little information about methodological approaches to combine and analyze multiple microbiome (16S amplicon) datasets. To address this gap, we conducted a scoping review of studies that combined 16S sequencing data from multiple sources to understand the objectives, data sources and selection, bioinformatics, and analyses. References were identified through a systematic search of literature published between January 2011 and April 2026. Our final review included 136 articles. Despite the widespread use of the word "meta-analysis," we found that only two-thirds of studies used a systematic process to select their dataset and 20% applied a statistical meta-analysis. Most studies (79%) combined datasets from multiple disjoint hypervariable regions. The number of hypervariable regions combined was not associated with the bioinformatic methods, but bioinformatics and the number of hypervariable regions influenced analytical resolution. Our results suggest that the microbiome community needs to examine the terminology and analytic approaches for combining datasets; that additional work is needed to explore the impact of data source on bias in combined studies; and that evaluation of methods used for feature table construction across disjoint regions is needed.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Cohen I, T Muth (2026)

Tradeoffs in Method Selection for Analyzing Full-Length 16S Data From Nanopore Sequencing in Defined and Environmental Microbiomes.

Ecology and evolution, 16(11):e74647.

Bacteria are found in nearly every environment on earth, and the ability to characterize bacterial communities is key to investigating a variety of scientific questions. One method for characterizing and comparing bacterial communities is to amplify and sequence the 16S ribosomal RNA gene and to use these sequences (A) to determine phylogenetic relationships within and between samples and (B) to assign a taxonomic identification to each sequence by comparison to reference databases. Nanopore sequencing technology has increased the accessibility and affordability of sequencing for full-length 16S ribosomal RNA genes, but existing workflows for analyzing these data are either not developed for the unique error profiles of Nanopore data or are recently developed and incompletely characterized. A detailed comparison between Nanopore-specific metabarcoding pipelines is needed to illustrate how the tradeoffs inherent in all metabarcoding workflows manifest in these pipelines, and to inform workflow selection for specific applications. Here we compare three pipelines: Emu, PRONAME, and wf-metagenomics to analyze microbiomes of simple and complex bacterial communities. We find that all three pipelines provide similar conclusions for environmental samples with respect to alpha and beta diversity and order-level taxonomy while reporting different taxonomic classifications and richness at the family, genus, and species levels. We find that all three can reliably identify genera in simple, defined communities. The comparisons provided here will aid those using Nanopore Sequencing for 16S metabarcoding to identify an appropriate analysis workflow for their intended question or application.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Yuan Y, E Linghu (2026)

The human body as a multi-organ coupled homeostatic organism: the core mechanism of the super minimally invasive surgery paradigm.

Frontiers in medicine, 13:1942429.

Super minimally invasive surgery (SMIS) has been proposed as a treatment paradigm in which minimally invasive care is evaluated not only by access-related trauma but also by treatment-induced biological disturbance and preservation of organ function. We hypothesize that, when disease-control adequacy is comparable, strategies associated with lower multidimensional homeostatic disturbance will be associated with faster functional recovery and better long-term organ- and patient-centered outcomes. We define an SMIS-concordant strategy by three conditions: adequate disease control; lower measurable treatment-induced disturbance than an appropriate comparator; and preservation or faster restoration of organ and systemic function. Homeostatic disturbance is operationalized as a multidomain construct that may include inflammatory/immune, neuroendocrine, metabolic/nutritional, organ-specific, barrier/microbiome/circadian, functional, and patient-reported domains. Because no validated universal score, weighting scheme, or threshold is available, we propose a comparative measurement matrix rather than a new composite index. The framework yields three falsifiable predictions: SMIS-concordant strategies should produce less early biological disturbance, support a faster return toward baseline, and provide prognostic information for long-term recovery beyond conventional perioperative measures. Early gastric cancer illustrates the approach: in guideline-eligible patients, endoscopic resection preserves the stomach and is associated with lower procedural burden and better quality of life, while preliminary proteomic data suggest less postoperative immune-inflammatory perturbation; gastrectomy remains indicated when curative criteria are not met. SMIS is therefore presented as an integrative treatment-decision framework that requires prospective validation.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Shirato S, Ikegami I, Sasaki T, et al (2026)

Bob1[+] T follicular helper cells support intestinal mucosal immunity.

Frontiers in immunology, 17:1980099.

INTRODUCTION: The intestinal environment relies on immunoglobulin A (IgA) produced in mucosa-associated lymphoid tissues, including Peyer's patches (PPs). While T follicular helper (Tfh) cells are known to facilitate germinal center (GC) formation in PPs, the mechanisms through which Tfh cells regulate IgA production remain unclear. B-cell Oct-binding protein 1 (Bob1), a transcriptional coactivator that interacts with octamer-binding transcription factors 1 and 2 (Oct1/2), is notably expressed in Tfh cells and regulates their function during persistent foreign antigen exposure.

METHODS: To explore the role of Bob1 in Tfh cells and intestinal immunity, we studied T cell-specific Bob1-deficient mice (CD4[Cre/+]Bob1[fl/fl], FoxP3[GFP/DTR]CD4[Cre/+]Bob1[fl/fl]) alongside control mice (CD4[+/+]Bob1[fl/fl], FoxP3[GFP/DTR]CD4[+/+]Bob1[fl/fl]) under steady-state conditions. We assessed differences in IgA production and subsequently analyzed T and B cell subsets involved in IgA production within the lamina propria (LP) and PPs. Additionally, we examined changes in the intestinal microbial composition in both groups.

RESULTS: Fecal IgA levels and the population of IgA[+] plasma cells in the small intestinal LP were significantly lower in CD4[Cre/+]Bob1[fl/fl] mice than in control CD4[+/+]Bob1[fl/fl] mice. Similarly, IgA[+] light zone GC B and IgA[+] memory B cells were found in reduced populations in PPs of CD4[Cre/+]Bob1[fl/fl] mice compared with those in the controls. Furthermore, inducible T-cell costimulator expression was diminished in GC Tfh cells of FoxP3[GFP/DTR]CD4[Cre/+]Bob1[fl/fl] mice compared with that in controls. Analysis of the intestinal microbiota also revealed a reduced abundance of Bacteroidales-associated bacterial populations, including the family Prevotellaceae and Rikenellaceae, in CD4[Cre/+]Bob1[fl/fl] mice.

CONCLUSION: Our findings indicate that Bob1 is crucial for Tfh cell activation in PPs, which in turn supports intestinal IgA responses and the maintenance of Bacteroidales-associated microbial communities. This study enhances our understanding of the mechanisms underlying intestinal immune responses and lays the groundwork for future research aimed at modulating mucosal immunity.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Liu Z, Mo W, Liang J, et al (2026)

Microbiome science in fecal microbiota transplantation for inflammatory bowel disease: a WoSCC-centered, three-database bibliometric and knowledge-mapping analysis, 2000-2025.

Frontiers in microbiology, 17:1948431.

BACKGROUND: Fecal microbiota transplantation (FMT) is an ecosystem-level microbiome intervention for inflammatory bowel disease (IBD), but bibliometric findings depend on indexing systems.

OBJECTIVE: To map the development and thematic evolution of FMT-IBD research from 2000 to 2025 and identify recurrent macro-level patterns across the Web of Science Core Collection (WoSCC), Scopus, and PubMed.

METHODS: After single-reviewer eligibility screening and within-database deduplication, 1,689 WoSCC, 2,697 Scopus, and 1,533 PubMed records were included. WoSCC served as the core analytical dataset, whereas Scopus and PubMed were parallel descriptive comparators; the datasets were not pooled or matched at record level. R/bibliometrix supported performance analysis, VOSviewer mapped database-specific term co-occurrence, and CiteSpace identified cited-reference and keyword bursts.

RESULTS: More than 94% of records in each database were indexed during 2015-2025. All three sources showed rapid growth, China and the United States as the leading corresponding-author countries, a multidisciplinary journal base, and recurring themes centered on FMT, IBD, ulcerative colitis, dysbiosis, and the gut microbiome. Detailed rankings remained source dependent. The cited knowledge base shifted from recurrent Clostridioides difficile infection efficacy and procedural standardization toward IBD trials, biosafety, formulations, strain engraftment, and microbiota-immune-metabolic mechanisms.

CONCLUSION: FMT-IBD research increasingly emphasizes strain-aware, function-oriented, and biosafety-conscious microbiome intervention. These patterns map the indexed literature and do not demonstrate that precision microbiome intervention has been achieved. Priorities include functional multi-omics, reproducible pipelines, biologically informed donor-recipient matching, and rigorous biosafety surveillance.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Rendina DN, Commichaux S, Roos S, et al (2026)

Daily supplementation with canine-isolated Limosilactobacillus reuteri ATCC PTA 6127 is well tolerated, improves stool consistency, and modulates gut microbiome in dogs.

Frontiers in veterinary science, 13:1970798.

Probiotics are increasingly incorporated into companion animal diets to support gastrointestinal function, yet strain-specific evidence in dogs remains limited. This study evaluated the safety, tolerability, and gastrointestinal effects of daily supplementation with Limosilactobacillus reuteri PureStrong™ (ATCC PTA 6127) in healthy adult dogs. Sixteen purpose-bred Beagle dogs (8/group; balanced by sex) were enrolled in a randomized, blinded, placebo-controlled trial and received either 1 × 10[8] CFU/d of L. reuteri ATCC PTA 6127 or placebo for 28 days. At study initiation, dogs underwent a standardized transition from a dry diet to a canned wet diet, representing a dietary challenge associated with transient gastrointestinal and microbiome changes. Safety was assessed through clinical observations, body weight, food intake, hematology, and serum biochemistry; gastrointestinal outcomes included daily fecal scoring and periodic measurement of fecal pH, moisture, and microbiome composition (16S rRNA gene sequencing). All dogs completed the study without adverse events, and clinical pathology values remained within reference intervals with no treatment-related differences. Dogs receiving L. reuteri exhibited a lower incidence of poorly formed stools compared with placebo (0.58% vs. 6.33%) and were significantly less likely to be assigned to poorer fecal consistency categories (β = -1.31, p = 0.033), indicating improved stool quality during supplementation. By Day 28, fecal pH was significantly lower in the probiotic group compared with placebo after baseline adjustment (Δ = -0.22; 95% CI: -0.403 to -0.045; p = 0.018). Microbiome analyses indicated that the transition from dry to wet food was the dominant driver of microbial community restructuring. Against this background, probiotic supplementation was associated with an early increase in fecal L. reuteri abundance and more positive longitudinal changes in several lactic acid bacteria and commensal taxa during the first 2 weeks. Most treatment-associated differences were no longer evident by Day 28. In summary, daily supplementation with L. reuteri ATCC PTA 6127 was safe and well tolerated and was associated with improved fecal consistency, lower fecal pH at Day 28, and transient differences in microbiome adaptation during a dietary challenge. These findings provide strain-specific evidence supporting the potential of ATCC PTA 6127 as a dietary probiotic supplement for gastrointestinal stability in dogs.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Tanprasertsuk J, Tate DE, Tarr DS, et al (2026)

Comparative shotgun metagenomic analysis of the feline fecal microbiome in response to fresh, dry, and wet diets in a randomized crossover trial.

Frontiers in microbiology, 17:2000915.

Fresh (mildly cooked) cat foods are an increasingly popular alternative to conventional extruded dry and retorted wet diets, differing in their processing and formulation. While the gut microbiota play an important role in feline health and physiological functions, characterization of the gut microbiome in cats fed fresh diets and direct comparisons with dry and wet diets have not yet been performed. In this 42-day, 3 × 3 Latin square crossover trial, 15 healthy adult cats received commercial, chicken-based, complete fresh, dry, and wet diets in one of three randomized diet sequences. Each diet was fed for 14 days, with fecal samples collected on days 12-14 for shotgun metagenomic sequencing, followed by taxonomic and functional annotation. Shannon and Simpson indices were lower with the dry diet than with the other two diets (p < 0.001 for fresh vs. dry, p < 0.01 for wet vs. dry for both indices), while Chao1 was higher for the wet diet than for the dry (p < 0.05) and fresh diets (p < 0.001). PERMANOVA using Bray-Curtis distances showed significant differences in species, pathway, and CAZy term compositions among diets (all p < 0.001). The five most abundant phyla with the fresh and wet diets were Bacteroidota, Bacillota_A, Actinomycetota, Pseudomonadota, and Bacillota, whereas Bacillota_C replaced Pseudomonadota when cats were fed the dry diet. Differential abundance analysis of taxonomic and functional data using MaAsLin2 identified diet-associated changes (FDR-adjusted p < 0.10). Collinsella, Bacteroides, and Blautia species were enriched and Prevotella species were depleted with the fresh compared with the dry diet, while Prevotella species were depleted with the fresh compared with the wet diet. The dry diet was associated with amino acid biosynthesis, bacterial cell envelope biosynthesis, and polysaccharide degradation; the fresh diet with amino acid degradation, lipid biosynthesis, and utilization of starch/glycogen, fructans, and host-associated glycans; and the wet diet shared functional similarities with the other two diets. The current study demonstrates differences in the feline fecal microbiome at the species level and in predicted functional profiles among fresh, dry, and wet diets, however health implications remain unclear before they can inform feeding recommendations.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Yang K, He S, Wang Q, et al (2026)

Exploratory integrated analysis of the microbiome and host transcriptome reveals correlations between the intratumoral microbiota and esophageal squamous cell carcinoma.

Frontiers in microbiology, 17:1974338.

BACKGROUND: The intratumoral microbiota can affect the occurrence, development, and prognosis of esophageal squamous cell carcinoma (ESCC) through various mechanisms. This study explored the relationship between key genes and key microorganisms in ESCC.

METHODS: A systematic multiomic integration pipeline was applied to analyze the transcriptomic and 16S rRNA sequencing data of cancerous and paracancerous tissues obtained from patients with ESCC. Differential expression analysis, protein-protein interaction networks, and machine learning algorithms were successively used to identify key host genes in ESCC. Notably, gene set enrichment analysis (GSEA) and immune infiltration analysis were employed to investigate relevant mechanisms. Subsequently, differential abundance analysis and machine learning were used to elucidate key intratumoral microorganisms. Finally, a combined multiomic analysis using the Data Integration Analysis for Biomarker discovery using Latent cOmponents (DIABLO) framework and Spearman correlation networks (CIRCOS) was employed to explore synergistic host-microbe associations.

RESULTS: TNNC2, CTHRC1, MMP10, CGAS, IL18, SERPINE1, CCNA1, and POSTN were identified as key genes. GSEA revealed that key genes were mainly involved in the cell cycle, indicating that cell cycle disorders might affect the progression of ESCC. The enrichment scores of seven types of immune cells significantly changed during ESCC progression. Additionally, 14 differentially abundant microorganisms were detected, and four key microorganisms were identified: Lachnoanaerobaculum, Fusobacterium, Actinomyces, and Capnocytophaga. Among them, Lachnoanaerobaculum was associated with multiple key genes, including POSTN, MMP10, CTHRC1, and CGAS. Exploratory DIABLO analysis highlighted concordant variation of the selected transcriptomic and microbiomic features between ESCC and adjacent nontumor tissue tissues.

CONCLUSION: Eight host genes and four microbial genera were identified as candidate ESCC-associated features. Given the small cohort and lack of independent validation, these findings should be considered preliminary and confirmation in larger independent cohorts is required.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Chen J, Tang B, L Zhou (2027)

Residual gastric cancer risk after Helicobacter pylori eradication: Mucosal immune trajectories (Review).

Oncology letters, 33(1):5.

Helicobacter pylori is the leading modifiable cause of noncardia gastric cancer. Eradication lowers the incidence of primary and metachronous gastric neoplasia, yet a clinically meaningful risk remains once extensive atrophy, intestinal metaplasia or dysplasia is established. Current surveillance incorporates infection status and structural disease burden but does not directly assess biological recovery of the gastric mucosa. The present review examined whether mucosal immune trajectories after eradication are heterogeneous and whether localized immune measurements could explain variation in residual risk beyond morphology and epithelial-field alterations. Single-cell and spatial studies of human tissue have identified infection- and precursor-associated changes in myeloid differentiation, antigen presentation, T-cell states, metaplastic epithelium and stroma. Longitudinal evidence is less developed. Selected mucosal T-cell measurements support reversibility of specific responses, whereas gene-expression, histologic and microbiome trajectories provide molecular, structural or contextual evidence. Outcome-linked CD8-associated trajectories provide the closest currently available clinical-outcome immune evidence, but remain non-functional proxies derived from a post-resection population. A 2026 human single-cell study further identified persistent stromal and immunosuppressive niche features in post-eradication chronic atrophic gastritis, but did not provide paired longitudinal immune-function measurements or prospective neoplastic outcomes. Among the studies identified through the present search, none combined confirmation of eradication, paired measurements of immune function, concurrent assessment of the epithelial field and prospective dysplasia or cancer outcomes in individuals without previous gastric neoplasia. Therefore, the available evidence supports heterogeneous tissue recovery rather than a validated persistent immune state. Clinical translation would require reproducible functional immune activity, or a functionally validated proxy, together with independent outcome association, external validation and a clinically meaningful improvement in surveillance decisions beyond established histologic staging and lesion extent. Until such evidence is available, candidate immune markers should remain research tools and should not modify guideline-based surveillance.

RevDate: 2026-11-19
CmpDate: 2026-11-19

Zoccali C, Glorieux G, Cianci R, et al (2026)

Microbiome science at the kidney-vascular interface: why translation to diagnostics and therapies still lags behind.

Clinical kidney journal, 19(11):sfag362.

The microbiome is a recognized modifier of immunity, metabolism, and vascular and neurological biology, with licensed therapeutics for recurrent Clostridioides difficile infection and promising applications in oncology and metabolic disease. By contrast, translation of microbiome knowledge into actionable therapies for kidney disease and hypertension remains limited. This review examines barriers to translation of microbiome effects at the kidney-vascular interface, considering mechanisms, metrics, and modifiers. Mechanistic association studies implicate microbially derived uremic toxins (indoxyl sulfate, p-cresyl sulfate, phenylacetylglutamine, trimethylamine N-oxide), short-chain fatty acids, and bile acid derivatives in kidney fibrosis, vascular and neurologic dysfunction, and blood pressure deregulation, while chronic kidney disease (CKD) and ensuing polypharmacy remodel oral and gut microbial communities. Candidate microbiome "metrics"-taxonomic signatures, diversity indices, and metabolite panels-lack standardization, show inconsistent replication across regions and ancestries, and provide uncertain incremental value beyond established risk markers. Interventional studies applying diets, exercise, pre-, pro-, syn-, and meta-biotics, sorbents, or fecal microbiota transplantation report modest improvements in surrogate outcomes (uremic solute concentrations, inflammatory markers, and blood pressure), but no convincing evidence for slower kidney function decline or fewer cardiovascular events; large controlled sorbent trials have been neutral on hard kidney endpoints. This review highlights cross-cutting obstacles, including complex confounding and reverse causation, reliance on stool-only sampling, temporal instability of microbial communities, analytic heterogeneity, strict regulation of live biotherapeutics, and inequities. Priorities to enable progress from plausible biology to clinically useful tools for CKD and hypertension include harmonized multiethnic longitudinal cohorts, multiomic integration, and mechanism-driven intervention trials.

RevDate: 2026-11-18

Watts AW, O'Malley C, Majdoubi A, et al (2026)

Infant RSV immunity study (IRIS): protocol for a prospective birth cohort in Vancouver, Canada examining how age at respiratory syncytial virus exposure affects how infants respond to the virus immunologically.

BMJ open, 16(11):e127619.

INTRODUCTION: Respiratory syncytial virus (RSV) is a leading cause of severe respiratory illness in infants. Age at first infection is strongly associated with disease severity. Infants exposed to RSV at a younger age may not produce an immune response against RSV that is as protective as infection at a later age, and early life infection may influence the risk of recurrent or persistent wheezing, or subsequent asthma. However, how immune development at the time of exposure shapes RSV-specific immunity and long-term respiratory health remains unclear.

METHODS AND ANALYSIS: The Infant RSV Immunity Study (IRIS) is a prospective birth cohort of 300 healthy infants in British Columbia, Canada, followed to age 3 years. The primary objective is to determine how age at exposure influences RSV-specific immunity and respiratory outcomes. Infants are enrolled in April–June or September–November so that they enter the peak RSV season at either more than 6 months or less than 6 months of age. Symptom-triggered oropharyngeal nasal swabs and post-season RSV serology will identify RSV infections. Birth, pre-season dried blood spot and post-season blood samples will assess RSV-specific antibody, neutralisation, functional antibody and T-cell responses. Clinical outcomes include medically attended respiratory illness, RSV hospitalisation, daily wheezing and inhaler use, and asthma risk at age 3 assessed using the Childhood Asthma Risk Tool. A subgroup of infants will undergo infection-timed blood samples ⁓2 weeks into their first RSV infection. Maternal RSV vaccination and antibody status will be examined as determinants of infant responses. A microbiome upper-airway sample will be collected from the infant at 2 weeks, pre-season and post-season, and around PCR-confirmed RSV infection. In addition, serial stool samples will be collected at 2 weeks, 3, 6, 9 and 12 months of age. Analyses will distinguish developmental, seasonal and infection-associated influences on microbiome and immune development trajectories and test associations with antiviral responses, disease severity and recurrent wheezing post-RSV infection. Infants’ diet will be assessed by serial questionnaires, as another determinant of microbiome development.

ETHICS AND DISSEMINATION: The study was approved by the University of British Columbia Children’s and Women’s Research Ethics Board (H25-02623). Findings will be disseminated through publications, scientific meetings and participant communication.

TRIAL REGISTRATION NUMBER: NCT07653347.

RevDate: 2026-11-17
CmpDate: 2026-11-17

Joshi D, Uniyal S, Singh SK, et al (2026)

Targeting Energy Metabolism and Tryptophan Pathways in Alzheimer's Disease for Developing Therapeutic Strategies.

Molecular neurobiology, 63(1):.

Alzheimer's disease (AD) is the primary cause of dementia worldwide and carries a high socioeconomic burden. However, despite the fact that such pathological features as amyloid-beta plaques and neurofibrillary tangles are considered hallmark traits of AD, therapeutic approaches targeting these pathological features have shown limited clinical efficacy to date. Recent scientific discoveries have drawn attention to the importance of metabolic processes preceding neurodegeneration. Reduced glucose utilization and impaired oxidative phosphorylation (OXPHOS) are associated with bioenergetic deficits that may increase neuronal vulnerability to damage. In addition, neuroinflammation is associated with altered tryptophan metabolism through the kynurenine pathway and may favor the production of potentially neurotoxic metabolites. Despite these separate aspects of AD, the interaction between impaired bioenergetics and altered tryptophan metabolism in the brain has not been sufficiently studied. This gap complicates the development of multi-targeted treatment strategies. The purpose of this narrative review is to examine how gut dysbiosis, immune activation, mitochondrial oxidative phosphorylation (OXPHOS) impairment, redox imbalance, and tryptophan-kynurenine pathway dysregulation interact and may contribute to AD development and progression, including associated neuropsychiatric symptoms. We examine whether NAD[+] depletion and rerouting of tryptophan metabolism may act as key nodes linking mitochondrial respiratory failure with the generation of neurotoxic kynurenine metabolites, excitotoxic glutamatergic signaling, loss of neurotrophic support, and synaptic dysfunction, and to analyze existing and emerging therapeutic strategies that target these interconnected pathways. In addition, this review highlights potentially promising interventions, such as NAD[+] precursor supplementation, central nervous system insulin delivery, and modification of gut microbiome. Here we propose that the energy-tryptophan metabolic axis is a promising but underexplored area of AD research. Targeting these convergent bioenergetic and metabolomic pathways may support precision intervention strategies that could extend beyond conventional amyloid-centric paradigms to address broader neurodegenerative and neuropsychiatric syndromes.

RevDate: 2026-11-17

Kim D, Oh Y, Kim J, et al (2026)

Investigation of Korean women's facial skin microbiome and the effects of aging.

Genes & genomics [Epub ahead of print].

BACKGROUND: The human skin microbiome alters with aging, yet the dynamic shift in how the microbial ecosystem responds to external hygiene habits versus intrinsic aging factors across life stages remains poorly understood.

OBJECTIVE: To investigate age-specific changes in the facial microbial community of Korean women and identify the ecological 'tipping point' where microbial composition and responses to daily cleansing habits fundamentally shift.

METHODS: We performed 16 S rRNA V3-V4 amplicon sequencing on facial swab samples from 94 Korean women across five decades (20-60 s). Taxonomic, alpha/beta-diversity, and predictive functional (PICRUSt2) analyses were integrated with clinical exposome metadata to evaluate age-stratified microbiome-host interactions.

RESULTS: While species richness remained stable, beta-diversity exhibited a strong trending toward structural divergence (p = 0.057) between the 40 and 50 s groups, indicating a mid-life ecological tipping point. In the 50 s, the core resident Staphylococcus collapsed drastically (from 23.33% in the 40 s to 3.87%), signaling the onset of microbial dysbiosis. Concurrently, the microbiome-derived 'Carotenoid biosynthesis' antioxidant pathway significantly deteriorated. Spearman correlation networks demonstrated that while local facial cleansing habits tightly regulated the microbiome in the pre-tipping group (20-40 s), this external regulatory efficacy completely decoupled in the post-tipping group (50-60 s), compelling surviving core taxa to rely on intra-microbial symbiotic networks.

CONCLUSION: Facial skin aging involves a discontinuous ecological tipping point during the 50 s characterized by structural dysbiosis, functional antioxidant depletion, and the collapse of external hygiene efficacy. Age-specific dermatological strategies for older demographics must transition from simple surface cleansing to customized interventions restoring microbial balance.

RevDate: 2026-11-18
CmpDate: 2026-11-17

Carvalho BFDC, Garcia MT, do Carmo PHF, et al (2026)

Dysbiosis in the Aerobic Microbiota of E-Cigarette Users: Evidence From Salivary Microcosm Biofilm.

Clinical and experimental dental research, 12(6):.

OBJECTIVES: Tobacco and nicotine are known to alter the oral microbiome, thereby promoting dysbiosis. The impact of new nicotine forms, such as electronic cigarettes (e-cigs), on oral dysbiosis remains unclear. This study aimed to evaluate the microbial biofilm composition and carbohydrate presence in e-cig users' saliva.

MATERIAL AND METH: Fifty participants with healthy oral mucosa were divided into two groups: E-cig group (EG)-25 regular and exclusive e-cig users; Control group (CG)-25 non-smokers, matched for sex and age. Unstimulated saliva and flavoring samples were collected. The salivary biofilm's biomass and metabolic activity were assessed, along with non-selective counts of general microorganisms, yeasts, Streptococcus mutans group streptococci, and lactobacilli in the microcosm biofilms. Total carbohydrate content in saliva was quantified using the phenol-sulfuric acid method.

RESULTS: The biomass average and the metabolic activity showed an increase in EG. The counts of non-selective microorganisms, yeasts, and mutans group streptococci were higher in EG compared with those in CG. Conversely, EG showed a reduction in lactobacilli counts in all samples. No differences were found in total carbohydrate content in saliva between EG and CG. However, significant carbohydrate presence was noted in the flavoring, particularly in fruit/sweet flavors.

CONCLUSIONS: The e-cig use promotes dysbiosis in the aerobic microbiota through a significant increase in biofilm formation and in the counts of S. mutans and oral yeast. Significant concentrations of glucose were detected in e-cig liquids, especially in sweet flavors.

RevDate: 2026-11-17

Miyahira AK, PJ Koo (2026)

The 32nd Annual Prostate Cancer Foundation Scientific Retreat Report.

The Prostate [Epub ahead of print].

BACKGROUND: The 32nd Annual Prostate Cancer Foundation (PCF) Scientific Retreat took place in Carlsbad, CA on October 23-25, 2025.

METHODS: The Annual PCF Scientific Retreat is a global forum for presenting the newest basic, translational, and clinical discoveries in prostate cancer, alongside work from related fields. Presentations highlight discoveries with strong potential to advance prostate cancer understanding, change clinical practice, and improve patient outcomes.

RESULTS: The 2025 PCF Retreat featured research and special lectures from many disciplines, including: (i) next-generation theranostics; (ii) emerging immunotherapy approaches in prostate cancer; (iii) understanding and drugging the epigenome; (iv) clinical trial updates; (v) artificial intelligence (AI) and machine learning; (vi) circulating biomarkers; (vii) harnessing the host microbiome in cancer; (viii) exercise interventions for patients with prostate cancer; (ix) CYP17A1-independent androgen biosynthesis as a mechanism of persistent androgen production; (x) Prostate Cancer Working Group 4 recommendations for trial design and response assessment; (xi) tissue-guided optimization of combination therapy; (xii) PCF Women in Science Lifetime Achievement Award lecture; and (xiii) bridging biomedical research and drug development.

CONCLUSIONS: The 2025 PCF Scientific Retreat illustrated how advances across diverse fields, including theranostics, immunotherapy, epigenetics, AI, and liquid biopsy, are converging to reshape how prostate cancer is understood, monitored, and treated. Recurring themes included tumor heterogeneity and lineage plasticity as determinants of treatment response, the need for predictive biomarkers to guide increasingly intensive and combination therapies, and the movement of effective therapies into earlier disease settings. This report reflects the state of the science as of October 2025.

RevDate: 2026-11-17

Narayan R, Le CC, Khurana JK, et al (2026)

Inhibitors of Gut Bacterial l-Dopa Decarboxylation with Reduced Susceptibility to Host Metabolism.

ACS chemical biology pii:5472025 [Epub ahead of print].

Microorganisms in the human gut influence the efficacy and metabolism of host-targeted small molecule therapeutics, including the frontline Parkinson's disease drug levodopa (l-dopa). Previous work has identified a mechanism-based inhibitor of gut bacterial decarboxylases that degrade l-dopa, α-fluoromethyltyrosine (AFMT). However, early experiments with AFMT in rodent models suggested undesirable in vivo metabolism by host tyrosine hydroxylase, producing α-fluoromethyldopa, a metabolite likely to worsen Parkinson's phenotypes and prevent application as an l-dopa cotreatment. Here, we demonstrate oxidation of AFMT to α-fluoromethyldopa in vitro by recombinant human tyrosine hydroxylase. We then develop AFMT analogues that retain activity against bacterial decarboxylases but have reduced susceptibility to host hydroxylation. Suitable arenes for inhibitor design were identified using assays with commercially available noncanonical amino acids, which revealed aryl difluorination as a promising modification. Difluoroaryl AFMT derivatives are less prone to degradation by tyrosine hydroxylase in vitro yet still inhibit l-dopa metabolism by bacterial decarboxylases. This work exemplifies how substrate reactivity can streamline design of mechanism-based enzyme inhibitors, as well as how constraints posed by the host can be incorporated during development of microbiome-targeted therapeutics. The compounds reported here are promising starting points for future studies in animal models and further exploration of gut bacterial effects on l-dopa treatment efficacy.

RevDate: 2026-11-17

Ahmadi F (2026)

Learning from nature: What non-native halophilic and halotolerant bacteria reveal about root immunity under salt stress.

Microbiological research, 316:128827 pii:S0944-5013(26)00391-5 [Epub ahead of print].

Soil salinity is increasingly recognised as one of the main limits to crop production worldwide, yet attempts to use halophilic and halotolerant plant growth-promoting bacteria in saline agriculture have produced mixed and often disappointing results, particularly when strains are moved onto non-native host plants. In this review, the literature is brought together to examine how such non-native halophilic and halotolerant bacteria behave at the root-soil interface under salt stress, and which molecular, physiological, and ecological factors determine whether they are rejected by, or can pass through, plant defence barriers. The article first summarises how salinity reshapes root immune organisation, from root system architecture and cell-wall properties to redox homeostasis and ABA-SA-JA signalling, and how these changes open and close specific spatial and temporal windows for microbial entry, recognition and persistence. Plant immune responses to native and non‑native halophilic bacteria are compared, revealing that differences in MAMP perception, PTI dynamics, and host-microbe feedback determine host preference and colonisation in saline rhizospheres. These findings are summarised in a mechanistic model describing six main bacterial tactics that modulate recognition, signalling, oxidative stress, hormonal balance, and cell‑wall-apoplast properties to evade or adjust host immunity. Looking across different plant-bacteria pairs and experimental setups, the review discusses why promising halophilic inoculants so often fail when transferred to new hosts, which trait combinations are repeatedly associated with successful non-native colonisation, and where the major gaps remain in in planta and systems-level evidence. Together, these points are used to argue that future microbiome-based strategies for salt-affected soils need to be designed around plant immune architecture, salinity-induced physiological states and ecological fit, rather than relying only on generic stress-alleviating traits.

RevDate: 2026-11-17

Mihoci AM, Socolov D, Dumitrescu RD, et al (2026)

The endometrial microbiome and reproductive outcomes following assisted reproductive technologies: A systematic review.

Journal of reproductive immunology, 178:105169 pii:S0165-0378(26)00338-4 [Epub ahead of print].

The endometrial microbiome has emerged as a potential determinant of endometrial receptivity and reproductive outcomes following assisted reproductive technologies (ART), although its clinical significance remains uncertain. This systematic review evaluated the association between endometrial microbiome composition and reproductive outcomes after ART and critically appraised the evidence supporting microbiome-guided diagnostic and therapeutic strategies. The review was registered in PROSPERO (CRD420261405558) and reported in accordance with the PRISMA 2020 statement. PubMed/MEDLINE, Embase, Scopus, Web of Science Core Collection, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception to March 2026. Twelve studies involving more than 2200 women undergoing ART met the inclusion criteria. Across the included studies, Lactobacillus-enriched endometrial microbial profiles were associated with more favorable reproductive outcomes in some cohorts; however, findings were inconsistent across studies and individual endpoints, including implantation, clinical pregnancy, ongoing pregnancy, and live birth. Associations involving non-Lactobacillus microbial profiles were also heterogeneous and should be interpreted in the context of study-specific microbial definitions and patient populations. Preliminary non-randomized studies have reported favorable reproductive outcomes following microbiome-guided management in selected populations, but these findings do not establish treatment efficacy. However, substantial heterogeneity in study populations, microbiome assessment methods, definitions of dysbiosis, and outcome reporting limits the certainty and clinical applicability of the available evidence. Overall, current evidence supports a biologically plausible association between endometrial microbiome composition and reproductive outcomes following ART, but well-designed prospective studies using standardized methodologies are needed to determine whether endometrial microbial signatures can serve as clinically actionable biomarkers and therapeutic targets.

RevDate: 2026-11-17

Chen J, Zhang R, Zhang Z, et al (2026)

From plastic fragments to secondary microplastics: Long-term polymer aging and microbial functional responses at the sediment-water interface.

Journal of environmental management, 420:131357 pii:S0301-4797(26)02817-3 [Epub ahead of print].

Biodegradable plastics (BPs) are widely considered alternatives to conventional plastics, yet whether biodegradability reduces ecological impacts remains uncertain. Here, a 12-month sediment-water microcosm experiment was conducted to compare the aging behavior, microplastic (MP) generation, and microbial responses of polypropylene (PP), polylactic acid (PLA), poly(butylene adipate-co-terephthalate) (PBAT), and PLA/PBAT blends in urban river sediments. BPs exhibited accelerated oxidation, hydrolysis, and fragmentation compared with PP, with PLA/PBAT showing the greatest mass loss (9.74%) and releasing the highest MP abundance in sediments (217 particles g[-1]) and overlying water (14 particles mL[-1]). Metagenomic analyses revealed that biodegradable MPs reshaped microbial community assembly, interaction networks, and functional potentials by altering sediment carbon availability and environmental conditions. Notably, BPs enhanced microbial carbon acquisition, metabolic activity, and environmental sensing, while selectively restructuring virulence-associated gene profiles. The PLA/PBAT blend showed the strongest coupling among polymer degradation, microbial functional traits, and environmental filtering. These findings demonstrate that enhanced biodegradability does not necessarily translate into reduced ecological disturbance and highlight the need to integrate polymer aging dynamics, secondary MP generation, and microbially mediated responses into environmental risk assessments of biodegradable plastics.

RevDate: 2026-11-17

Torossian T, Choufany E, Bazzi S, et al (2026)

Beyond cytokines in inflammatory bowel disease: targeting the epithelial microbiome-mitochondria-immune axis to restore metabolic homeostasis.

Inflammatory bowel diseases pii:9080960 [Epub ahead of print].

Inflammatory bowel disease is a chronic inflammatory disease characterized by mucosal immunity dysregulation, epithelial barrier dysfunction, and gut microbiome dysbiosis. While cytokine-targeted therapies have improved clinical outcomes, many patients remain refractory or relapse, emphasizing the need for additional therapeutic approaches. Recent evidence suggests that mitochondrial metabolism in the intestinal epithelium regulates mucosal homeostasis, immune cell recruitment, and susceptibility to inflammation. However, it remains controversial whether mitochondrial dysfunction is a cause or a consequence of intestinal inflammation. Epithelial energetic deficiency and barrier dysfunction are associated with impaired oxidative phosphorylation, defective short-chain fatty acid utilization, redox imbalance, and faulty mitochondrial quality control. Indeed, impaired mitophagy promotes mitochondrial DNA (mtDNA) release through voltage-dependent anion channel 1 (VDAC1) oligomerization and mitochondrial permeability transition pore opening. Extracellular mtDNA acts as a damage-associated molecular pattern, activating cyclic GMP-AMP synthase-stimulator of interferon genes, toll-like receptor 9, and NLR family pyrin domain-containing 3 inflammasome pathways that amplify mucosal inflammation. These metabolic changes alter luminal oxygen and microbiome composition, whereas microbial metabolites, particularly tryptophan-derived indoles and kynurenines, modulate epithelial mitochondrial function through aryl hydrocarbon receptor signaling. These findings support a bidirectional microbiome-mitochondria-immune axis that potentiates intestinal inflammation. In this review, we summarize the current evidence of how epithelial mitochondrial dysfunction associates with intestinal inflammation. We discuss how mitochondrial metabolism interfaces with microbial ecology and immune regulation to shape disease pathogenesis. We also discuss therapeutic strategies targeting this axis: mitochondrial-targeted antioxidants (eg, MitoQ), VDAC1 inhibitors, bile-acid derivatives (eg, tauroursodeoxycholic acid), and metabolite-based therapies to restore microbial tryptophan metabolism. These approaches target mitochondrial bioenergetics and microbial metabolic cross-talk with the potential to restore microbiome-immune homeostasis, preserve barrier integrity, and complement conventional immune-directed therapies.

RevDate: 2026-11-17

Wang P, Yang J, Li S, et al (2026)

Spatial Transcriptomic Analysis Suggests Inflammatory Heterogeneity and Stromal-Epithelial Transcriptional Differences in Peri-Implantitis Tissues.

Journal of clinical periodontology [Epub ahead of print].

AIM: To explore spatial inflammatory heterogeneity and associated stromal-epithelial transcriptional differences in peri-implantitis tissues using high-resolution spatial transcriptomics.

MATERIALS AND METHODS: This exploratory study applied Visium HD spatial transcriptomics to five peri-implantitis lesions and four tooth-associated healthy gingival reference tissues. Spatial barcodes were annotated by histology, marker expression and module scoring. BANKSY, GASTON, differential expression, Gene Ontology, public scRNA-seq reanalysis, CellChat and multiplex immunofluorescence were used to assess inflammatory niches, stromal and epithelial gradients, epithelial gene sets and inferred signalling.

RESULTS: Peri-implantitis lesions showed descriptively greater immune-cell enrichment in an unmatched comparison with tooth-associated gingival reference tissue. Fibroblasts in inflammation-enriched niches differed from stromal-region fibroblasts and COL11A1-positive fibroblasts localised near immune-rich areas. GASTON identified graded expression patterns along the epithelial-stromal interface and epithelial regions. An 11-gene epithelial-inflammation-associated set showed region-associated expression differences, with supportive expression trends in public epithelial scRNA-seq data. CellChat suggested descriptively increased epithelial outgoing signalling involving WNT5A, MIF and ANXA1.

CONCLUSIONS: This study spatially describes host responses in peri-implantitis, including regional inflammatory heterogeneity, fibroblast-state variation and epithelial transcriptional differences. The epithelial-inflammation-associated gene set requires further validation. Interpretation should account for the small sample size, tooth-associated gingival reference tissue, absence of microbiome profiling and barcode-level Visium HD data.

RevDate: 2026-11-17

Jensen M, Corbella M, Stenfelt L, et al (2026)

Molecular basis for the efficiency of an Akkermansia muciniphila α-1,2-fucosidase on conjugated H and Lewis epitopes.

Structure (London, England : 1993) pii:S0969-2126(26)00329-1 [Epub ahead of print].

H and Lewis antigens are ABO blood group precursors and modulators of microbe-host interactions. Enzymatic removal of 1,2-fucosyl units in these antigens is pivotal for glycoengineering applications, e.g., within transfusion medicine. How α-1,2-fucosidases recognize multiple H and Le antigens remains unexplored, which we investigate in AmGH95B, an α-1,2-fucosidase from the gut symbiont Akkermansia muciniphila. Substrate binding was shown to trigger a conformational switch to the catalytically competent enzyme state via loop rearrangements. We also identified structural features underpinning the recognition of H and Lewis antigens with diverse fucosylation and mainchain linkages by the same binding subsites, including a previously undescribed secondary fucosyl binding site. Mutagenesis revealed that the glycan context of conjugated substrates is sensed by the enzyme, which has not been previously shown in α-fucosidases. This study unravels an unprecedented recognition across 4-5 saccharide units by an α-1,2-fucosidase and provides a framework for tailoring α-1,2-fucosidases for biomedical applications.

RevDate: 2026-11-17

Zhang Y, Nie R, Chen Z, et al (2026)

Diet-microbiome interaction shapes stress susceptibility via a gut-brain neurometabolic circuit.

Cell metabolism pii:S1550-4131(26)00451-1 [Epub ahead of print].

Dietary patterns shape mood and behavior, yet the microbial signals and neurosensory mechanisms underlying these effects remain unclear. Here, we identify a microbiota-mediated gut-brain circuit that dynamically regulates stress susceptibility during high-fat diet (HFD) exposure. Short- and long-term HFD differentially alter L-pipecolic acid (L-PipA), a metabolite produced by bacterial pyrroline-5-carboxylate reductase and sensed by oxytocinergic neurons in the paraventricular hypothalamus (PVH). Supplementation with L-PipA, either through its native producer Alistipes dispar or a bioengineered bacterial strain, promotes stress resilience, an effect mechanistically linked to ferritin heavy chain 1 (FTH1)-associated oxytocin secretion and a neural circuit linking PVH oxytocinergic neurons to lateral septal γ-aminobutyric acid (GABAergic) neurons. In humans, circulating L-PipA levels are reduced in patients with depression but increased in healthy volunteers following a 5-day HFD intervention. Together, these findings reveal a diet-microbiome-neural circuit axis regulating stress-related behaviors and suggest a potential strategy for enhancing stress resilience.

RevDate: 2026-11-17

Nasrallah A, El Mir J, Fayyad-Kazan M, et al (2026)

Inflammation at the Crossroads of UV Radiation and Pollution: The Molecular Synergy Behind Accelerated Skin Aging.

Toxicology letters pii:S0378-4274(26)02463-X [Epub ahead of print].

The skin exposome which is the cumulative sum of environmental exposures and their biological imprint from conception to death remains an underexplored driver of premature skin aging, despite the skin's unique accessibility as a model organ. Ultraviolet (UV) radiation and polycyclic aromatic hydrocarbons (PAHs), notably benzo[a]pyrene (BaP), are two of the most pervasive and co-occurring extrinsic stressors acting directly on the skin surface. While each independently disrupts redox homeostasis, genomic integrity, and immune function, their combined exposure produces a supra-additive, non-linear interaction now termed "oxinflammation" whose magnitude depends critically on UV dose, pollutant concentration, and exposure duration, ranging from adaptive responses at low, acute exposures to persistent, maladaptive inflammatory activation under chronic, cumulative co-exposure. Building on this dose- and time-dependent framework, and extending beyond prior reviews that have treated UV and air pollution as parallel or additive threats to skin aging, this review centers on the immuno-inflammatory circuitry underlying their synergy particularly crosstalk between the aryl hydrocarbon receptor (AhR), mitogen-activated protein kinase (MAPK), and NF-κB pathways and its role in driving chronic low-grade inflammation ("inflammaging"), cellular senescence, and senescence-associated secretory phenotype (SASP) accumulation. We further examine PAH-driven immunomodulation and skin microbiome disruption as emerging, underappreciated contributors to this inflammatory circuit. Recent proteomic, metabolomic, and epigenetic evidence is synthesized to describe how this interplay impairs autophagy and DNA repair, degrades collagen through matrix metalloproteinase and cathepsin activation, and compromises epidermal barrier integrity, collectively accelerating extrinsic skin aging and contributing to the elevated carcinogenic risk associated with cumulative UV-pollutant co-exposure. We critically evaluate emerging therapeutic strategies including Nrf2 activators, mitochondria-targeted antioxidants, AhR antagonists, NAD+-restoring compounds, barrier-repair technologies, and microbiome-modulating interventions together with their translational limitations, such as poor cutaneous bioavailability of key candidate molecules. Finally, we outline future research priorities, emphasizing systematic dose-response characterization, multi-omics integration, advanced 3D and human-on-chip skin models, and personalized exposome analytics as necessary steps toward precision prevention of environmentally induced skin aging and its downstream oncological consequences.

RevDate: 2026-11-17

Yan L, Xurui W, Zhangtian T, et al (2026)

Podophyllotoxin-induced mammary gland injury via the gut-mammary gland axis mediated by gut microbiota-derived metabolite PAG and aberrant EGFR signaling in SD rats based on the toxicological evidence chain (TEC) concept.

Chemico-biological interactions pii:S0009-2797(26)00541-7 [Epub ahead of print].

Podophyllotoxin is a lignan isolated from Dysosma versipellis with well-established antitumor activity. In this study, we applied an upgraded toxicological evidence chain 2.0 framework to characterize podophyllotoxin-induced mammary toxicity in female rats and to probe the distal regulatory mechanism operating through the gut-mammary axis. Repeated oral exposure provoked acute toxic signs in the animals, and histomorphometric analysis revealed a significant loss of collagen fibers in mammary tissue. 16S rRNA sequencing showed reduced gut microbial diversity, marked expansion of the opportunistic pathogen Escherichia_710834, and concurrent depletion of short-chain fatty acid producers such as Ligilactobacillus. Raman spectroscopy combined with targeted metabolomics uncovered 53 differentially abundant metabolites. Among these, four microbial-derived compounds-p-cresol, phenylacetylglycine, skatole, and trimethylamine N-oxide-correlated positively with Escherichia_710834 abundance. Further screening prioritized phenylacetylglycine and the epidermal growth factor receptor as the most credible ligand-receptor pair. Microscale thermophoresis confirmed a strong direct interaction, and qPCR revealed upregulated expression of downstream genes linked to proliferation and inflammation. Together, our findings define a complete causal pathway: podophyllotoxin perturbs the gut microbiome, driving excess production of phenylacetylglycine, which enters the circulation, engages mammary epidermal growth factor receptor, and aberrantly activates transcriptional responses that ultimately culminate in mammary tissue damage.

RevDate: 2026-11-17

Gu Y, Fu S, Wu H, et al (2026)

Combined metagenomic and metabolomic characterization of rhizosphere responses to GLDA-assisted cadmium phytoextraction by Artemisia argyi.

Environmental research pii:S0013-9351(26)02526-0 [Epub ahead of print].

Biodegradable chelator-assisted phytoextraction is widely proposed for cadmium (Cd)-contaminated farmland. In this study, we investigated the effects of the tetrasodium N,N-bis(carboxymethyl)-L-glutamic acid (GLDA) on Cd uptake by Artemisia argyi, and how rhizosphere functional gene abundances and metabolites co-vary across a GLDA dose gradient (0-5.00 mmol·kg[-1]; G0-G4) in a 65-day pot experiment. GLDA addition increased the exchangeable Cd fraction (8.8%-14.5%) and DTPA-extractable Cd (10.7%-18.6%), raising total plant Cd accumulation by 22%-36% and soil Cd removal rate from 4.87% (G0) to 5.93%-6.63% (G1-G4). GLDA selectively enhanced Cd accumulation in stems (11.11 to 25.17 mg·kg[-1]) without increasing Cd in the roots or leaves. Antioxidant enzyme activities (SOD, CAT, APX, GR) and glutathione content were higher under GLDA addition, but oxidative stress was not alleviated. GLDA addition was accompanied by a distinct restructuring of the rhizosphere microbiome and metabolome. Metagenomics showed enrichment of plant growth-promoting rhizobacteria (Bradyrhizobium, Paraburkholderia, Pandoraea, Ramlibacter, and Burkholderia), and higher relative abundances of genes for assimilatory sulfate/nitrate reduction, the glyoxylate cycle, glutathione synthesis, and Cd resistance. Soil metabolomics showed a contraction of the soluble oligosaccharide pool, suggesting reduced availability of soluble sugars in the rhizosphere. These biological shifts co-occurred with the chemical mobilization of Cd, representing a concurrent rhizosphere response during phytoextraction. Overall, these findings suggest that GLDA-assisted phytoextraction by A. argyi is a highly efficient remediation approach and simultaneously promotes a beneficial rhizosphere microbiome, providing a practical solution for Cd-contaminated soils.

RevDate: 2026-11-17

Ripa JD, Yeshi K, Field M, et al (2026)

Molecular Landscape of Inflammatory Bowel Disease: From Molecular Mechanisms to Emerging Pharmacological Strategies.

European journal of pharmacology pii:S0014-2999(26)01060-5 [Epub ahead of print].

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, broadly classified into ulcerative colitis and Crohn's disease, that affects millions of people worldwide. Despite significant advances in therapeutic options, including biologics, small-molecule drugs, and microbiota-targeted therapies, the aetiology of IBD remains incompletely understood. There is currently no curative treatment, and many patients experience suboptimal responses or severe treatment-related adverse effects. Increasing evidence suggests that IBD results from a complex interplay of genetic susceptibility, impaired epithelial barrier integrity, dysregulation of innate and adaptive immune responses and altered host-microbiome interactions. These disruptions trigger key inflammatory pathways and receptors, such as TNF receptors and IL-23R signalling, which sustain intestinal inflammation and contribute to disease severity and therapeutic resistance. This review summarises current understanding of IBD pathogenesis and highlights both established and emerging molecular targets. It also critically evaluates recent advances in drug discovery and targeted delivery strategies. By integrating mechanistic insights with translational approaches, this review aims to support the development of more effective, mechanism-driven, and personalised therapies for IBD.

RevDate: 2026-11-17

Chhiba KD, MC Berin (2026)

Immune Mechanisms of Oral Tolerance in the Prevention of IgE-Mediated Food Allergy.

The Journal of allergy and clinical immunology pii:S0091-6749(26)00814-6 [Epub ahead of print].

IgE-mediated food allergy develops when the immune response to dietary antigens is diverted from active tolerance towards a pathogenic type 2 immune response. Oral tolerance is the default, antigen-specific suppression of immune responses to ingested proteins. Early introduction trials, most notably the LEAP study, have demonstrated that oral exposure to food antigens during the first year of life can prevent food allergy and generate durable tolerance. Mechanistic advances have revealed that oral tolerance is governed by the coordinated activity of multiple overlapping immune layers. These include transcellular antigen transport through goblet cell-associated antigen passages (GAPs), tolerogenic antigen presentation by specialized RORγt+ antigen presenting cells (APCs) and classical dendritic cells (cDCs), induction and maintenance of heterogeneous regulatory T cell programs, and germinal center regulation of IgE and IgG responses. These cellular programs are further modulated by genetic determinants including HLA class II alleles, filaggrin variants, and microbial metabolites such as butyrate and indole derivatives and non-allergic dietary components. Infections can break tolerance by displacing or reprogramming tolerogenic APCs. Once food allergy has been established, regulatory pathways generated by oral allergen exposure are not sufficient to establish tolerance. These findings support a model in which tolerance and allergy represent competing, self-reinforcing immune states stabilized by redundant regulatory circuits. This review synthesizes the current understanding of these multilayered mechanisms and discusses their implications for prevention and treatment of food allergy.

RevDate: 2026-11-17

Coleon A, Ronco I, Raber J, et al (2026)

Molecular basis of behavioral and cognitive changes induced by neurotropic viruses.

Brain, behavior, and immunity pii:S0889-1591(26)01021-4 [Epub ahead of print].

Neurotropic viruses induce behavioral and cognitive alterations through diverse molecular and cellular mechanisms that extend beyond simple neuronal damage. Comparative analysis of rabies virus (RABV), pseudorabies virus (PRV), Borna disease virus (BoDV-1), SARS-CoV-2, Nipah virus (NiV), West Nile virus (WNV) and Herpes Simplex virus 1 (HSV-1) reveals distinct pathogenic strategies targeting specific neural circuits. While neuroinflammation characterized by microglial activation, astrocytic responses, and pro-inflammatory cytokine production contributes significantly to synaptic and network dysfunction in WNV and NiV infections, other mechanisms predominate in different pathogens. RABV selectively disrupts cholinergic, serotonergic, and glutamate/GABAergic pathways while preserving neuronal integrity to facilitate transmission, whereas BoDV-1 and SARS-CoV-2 induce dopaminergic and serotonergic dysfunctions through persistent immune activation and endothelial damage. Additionally, systemic factors such as the gut-brain axis and microbiome alterations, particularly evident in SARS-CoV-2 infection, modulate neurotransmitter metabolism and neuroimmune responses. Considering the lack of even diffuse neuronal loss observed during infection, behavioral changes may arise more from selective, circuit-dependent vulnerabilities, involving specific disruptions to emotion, cognition, and motor control networks. To provide a clear review of the knowledge regarding how targeted neuronal population alterations translate into behavioral phenotypes, we here integrate molecular, cellular, and systems-level insights across these seven neurotropic viruses used as models, with the aim of identifying common pathways linking infection to behavioral changes and cognitive dysfunction. Understanding these discrete mechanisms ranging from acute synaptic manipulation to long-lasting neuroimmune dysregulation is essential for developing therapeutic strategies that address both the infectious agent and the specific neural networks mediating acute disturbances and long-term neurological sequelae.

RevDate: 2026-11-17

Fontes BLM, Aguiar JD, da Costa ALC, et al (2026)

Microplastics And Nanoplastics In Soils: Inconsistent Evidence And Unresolved Toxicological Risks For Terrestrial Invertebrates.

Environmental toxicology and pharmacology pii:S1382-6689(26)00312-1 [Epub ahead of print].

Microplastics (MPs) and nanoplastics (NPs) accumulate in soils, but their risks to terrestrial invertebrates supporting soil formation, nutrient cycling, and pollination remain uncertain. We critically examine exposure and toxicity evidence for earthworms, fruit flies, bees, and tenebrionid beetles. Across taxa, oxidative stress, intestinal and epithelial injury, and microbiome disruption recur, whereas reproductive, immune, and behavioral effects are less consistent and often observed at high concentrations. Proposed mechanisms include mitochondrial and lysosomal dysfunction and altered antioxidant defenses, although causal links to organism-level outcomes remain limited. Comparisons are constrained by incomplete particle characterization, reliance on pristine particles, unrealistic exposures, and heterogeneous protocols. Insects can biofragment, depolymerize, and partially mineralize plastics, but the extent and ecological relevance of biodegradation remain contested, and fragmentation may generate smaller plastic particles. Progress requires environmentally relevant experiments using characterized, weathered particles, mechanistic endpoints linked to ecologically meaningful outcomes, and tiered risk assessment.

RevDate: 2026-11-17

Tanaka T, Ueki R, Fukuda R, et al (2026)

Species-specific bacteriophage-mediated engineering of an artificial microbiome composed of Bacteroides and Phocaeicola species.

New biotechnology pii:S1871-6784(26)00139-1 [Epub ahead of print].

Members of the Bacteroides and Phocaeicola genera have been involved in various health- and disease-related states, but their in situ functions have not been clearly elucidated yet. Targeted removal of specific bacterial species using bacteriophages is expected to facilitate in situ functional analysis of gut bacteria. However, the feasibility of species-specific removal in microbiomes including Bacteroides and Phocaeicola species has not been demonstrated, in part due to the limited availability of isolated phages infecting these taxa. We newly isolated two lytic phages infecting Bacteroides uniformis or Bacteroides caccae and evaluated their applicability for species-specific microbiome engineering using an artificial microbiome composed of five Bacteroides and two Phocaeicola species formerly classified as Bacteroides. Adding the B. uniformis phage selectively suppressed the growth of B. uniformis, resulting in 1.16 × 10[5] CFU-equivalent/mL in the presence of the phage compared with 6.01 × 10[7] CFU-equivalent/mL in the absence of the phage, without affecting the growth of nontarget species. In contrast, adding the B. caccae phage decreased the abundance of B. caccae and also significantly increased the bacterial abundance of the nontarget species Bacteroides finegoldii. This growth enhancement was likely mediated, at least in part, by cellular components released upon lysis of B. caccae. The results indicate that species-specific bacteriophage-mediated microbiome engineering is feasible within a defined Bacteroides/Phocaeicola community and can be a basis for subsequent functional analyses and for exploring interspecies growth interactions.

RevDate: 2026-11-17

Li W, Wu Y, Cheng M, et al (2026)

Biomarkers and molecular determinants of T-cell engager response, resistance and toxicity.

Biochemical pharmacology pii:S0006-2952(26)00996-2 [Epub ahead of print].

T-cell engagers redirect endogenous T cells against malignant cells and have produced clinically meaningful responses across haematological malignancies and selected solid tumours. Responses vary, while cytokine release syndrome, neurotoxicity, infection and on-target, off-tumour injury constrain treatment. Target positivity alone is therefore insufficient for selecting patients, molecules or dosing strategies. This Review synthesises evidence across five interacting domains: host immune reserve and T-cell fitness; engager molecular design and pharmacology; tumour antigen ecology and genomic vulnerability; the tumour immune ecosystem; and toxicity risk. Productive engagement requires functionally competent T cells, adequate active exposure at the tumour site, accessible and persistent antigen, tissue trafficking and calibrated T-cell activation. Candidate host markers include circulating lymphocyte and T-cell subsets, differentiation and exhaustion states, systemic inflammation, prior immunotherapy and microbiome-metabolic features. Molecular format, pharmacokinetics, activation threshold and synapse geometry influence the balance between cytotoxicity and systemic inflammation. Antigen density, coverage, accessibility, heterogeneity and treatment-induced loss shape sensitivity and resistance, whereas suppressive immune cells, stroma and metabolic constraints restrict tissue activity. Circulating tumour DNA, measurable residual disease and soluble antigen can support longitudinal response assessment. Baseline inflammation, cytokine kinetics and normal immune-lineage depletion may inform safety monitoring, but risk factors, pharmacodynamic changes, early-warning signals and manifestations of established toxicity serve different purposes. Most reported markers remain prognostic, pharmacodynamic or useful for resistance classification rather than validated predictors of treatment benefit. Clinical translation requires standardised assays, context-specific thresholds, external validation and prospective trials showing that biomarker-guided decisions improve patient outcomes.

RevDate: 2026-11-17

Liu DY, Zhang F, Ding K, et al (2026)

Bidirectional interplay of the gut microbiota and herbal medicine in Alzheimer's disease: mechanisms and therapeutic prospects.

Journal of ethnopharmacology pii:S0378-8741(26)01474-1 [Epub ahead of print].

Alzheimer's disease (AD) is a progressive neurodegenerative disorder in which alterations in the gut microbiota and microbiota-gut-brain axis (MGBA) may contribute to disease-related pathological processes. Herbal medicines have long been used for memory impairment and age-related cognitive disorders and contain bioactive constituents with diverse molecular targets. Increasing evidence suggests that herbal interventions can modulate the gut microbiota, while gut microorganisms can biotransform selected herbal constituents and influence their absorption and biological activity. These reciprocal interactions provide a mechanistic basis for investigating herbal medicine in AD.

AIM OF THE REVIEW: This review summarizes the bidirectional interactions between herbal medicine and the gut microbiota in AD, focusing on microbial composition and metabolites, intestinal barrier function, herbal biotransformation and bioavailability, signaling pathways, and multi-omics approaches.

MATERIALS AND METHODS: A structured narrative literature review was conducted using PubMed, Web of Science, and ScienceDirect for studies published from January 2010 to June 2026. Google Scholar searches and reference-list screening supplemented the database searches. Human, animal, and in vitro studies concerning AD, gut microbiota, herbal interventions, microbial metabolites, biotransformation, and bioavailability were included according to predefined eligibility criteria.

RESULTS: Herbal formulas, extracts, and compounds have been reported to alter gut microbial composition and metabolite profiles, improve intestinal barrier integrity, and influence inflammatory, oxidative, amyloid-β (Aβ)-related, and synaptic pathways relevant to AD. Conversely, the gut microbiota can biotransform selected herbal constituents, thereby altering their absorption and pharmacological properties. Integrated microbiome-metabolome studies also link microbial taxa, metabolites, and host signaling pathways, but most findings remain preclinical or correlational.

CONCLUSIONS: The bidirectional interaction between herbal medicine and the gut microbiota may be relevant to AD treatment. However, current evidence is largely preclinical and clinical validation remains limited. Future studies should clarify microbiota-dependent biotransformation and pharmacokinetics, standardize herbal formulas and dosing, establish causal microbe-metabolite-host relationships, assess long-term safety and herb-drug interactions, and conduct rigorous clinical trials before translation into AD management.

RevDate: 2026-11-17
CmpDate: 2026-11-17

Wu XP, Wang JA, Liu ZY, et al (2026)

[Exploring research value and application prospects of intestinal organoids in prevention and treatment of cardiovascular diseases with TCM based on theory of "gut-heart axis"].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 51(20):5740-5748.

Cardiovascular diseases(CVD) cause a major burden on global health, and their occurrence and development are closely related to gut microbiome dysbiosis and intestinal barrier dysfunction. The theory of "gut-heart axis" reveals the complex bidirectional regulatory network between the gut and the cardiovascular system, providing new avenues for the prevention and treatment of CVD. TCM has unique advantages in preventing and treating CVD due to its multi-target and holistic regulatory effects, whereas the molecular mechanisms through which TCM acts via the "gut-heart axis" require further elucidation. Intestinal organoids, as three-dimensional in vitro models that highly simulate the structure and function of the intestine in vivo, provide a crucial platform for mechanism research. According to the theory of "gut-heart axis" and the technical advantages of intestinal organoids, this article systematically explores how to utilize intestinal organoids to delve into the material basis and pathways of TCM interventions for CVD from multiple dimensions, including intestinal barrier integrity, immune regulation, metabolites, and neuroendocrine mechanisms, aiming to promote the modern development of TCM research and provide new strategies and ideas for the prevention and treatment of CVD.

RevDate: 2026-11-17
CmpDate: 2026-11-17

Dawod SM, DW Victor (3rd) (2027)

Diagnosis and Management of Hepatic Encephalopathy.

Clinics in liver disease, 31(1):45-57.

Hepatic encephalopathy (HE) is a neuropsychiatric complication of acute and chronic liver disease driven by hyperammonemia, systemic inflammation, and portosystemic shunting within the gut-liver-brain axis. Astrocyte dysfunction mediates cerebral swelling in acute liver failure and metabolic disturbances in cirrhosis-associated HE. Diagnosis is clinical, as serum ammonia correlates poorly with severity. Management encompasses identification of precipitating factors, lactulose and rifaximin therapy, nutritional optimization, and shunt-directed interventions in refractory cases. Emerging microbiome-based therapies show promise. HE significantly increases hospitalization, mortality, and caregiver burden, underscoring the need for coordinated multidisciplinary care.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Gurri FD, Peña-Ramírez YJ, Ruiz-García W, et al (2026)

From Self-Provisioning Agriculture to Store-Bought Foods: How Adaptive Choices Shape Gut Microbiome Maturation and Metabolic Vulnerability in Rural Maya Populations From Yucatan, Mexico.

American journal of human biology : the official journal of the Human Biology Council, 38(11):.

OBJECTIVES: Determine how increased reliance on store-bought foods alters gut microbiota composition, maturation, and ecological vulnerability in the first 36 months of life in Maya agriculturalists.

METHODS: Shotgun metagenomic data from stool samples of 23 rural Maya mothers, their infants and children under 36 months from households classified by their dependence on cash generating activities as traditional or "transformed" were collected. Microbial community structure was examined using Bray-Curtis clustering, permutational analysis of variance (PERMANOVA), and ecological network modeling. A contemporaneous 24-h food portions study was collected, and nutrient intake was correlated with microbial taxa.

RESULTS: Children from "transformed" households clustered with infants and showed reduced microbial diversity, simplified interaction networks, and higher relative abundances of Bacteroides, Bifidobacterium, and Streptococcus. In contrast, children from traditional households clustered with adults and exhibited higher diversity and enrichment of fiber-adapted taxa, including Clostridium, Prevotella, Faecalibacterium, and Ruminococcus. Network analyses indicated less-integrated, weakly regulated microbial communities in "transformed" children and infants, whereas traditional children and adults displayed denser, competitively structured networks. Diet-microbiome correlations were stronger and more directional in "transformed" children and infants, with positive associations with carbohydrate and fiber intake and widespread negative associations with saturated fat, whereas in traditional children and adults, associations were fewer and weaker.

CONCLUSIONS: Early-life exposure to market-based diets disrupts microbiome maturation, maintaining developmentally immature and diet-sensitive ecosystems beyond infancy. This instability may increase developmental mismatch and metabolic vulnerability in children from nutritionally transitioning populations.

RevDate: 2026-11-17

Pylro VS, Del Bem LEV, DK Morais (2026)

Plant autonomy in a function-rich microbial world.

Trends in microbiology pii:S0966-842X(26)00311-2 [Epub ahead of print].

Plants evolved in environments where microbes already performed key ecological functions. We hypothesize that persistent access to reliable microbial functions may have shaped plant autonomy, favoring reduced investment in costly autonomous processes. We distinguish this from plant-microbe coevolution and propose predictions testable with comparative genomics, crop wild relatives, and experimental evolution.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Rodríguez-Blanco PM, Zitlalpopoca-Hernández G, González-Holgado MG, et al (2026)

Herbivory-triggered assemblage of sunflower rhizosphere microbiome enhances herbivore tolerance through plant-soil feedback.

NPJ biofilms and microbiomes, 12(1):.

Rhizosphere microbial communities are key drivers of plant immunity and stress responses, and plants recruit beneficial microorganisms under stress. Herbivorous insects pose a major agricultural challenge, yet how leaf herbivory influences root-associated microbiomes and whether these changes generate plant-soil feedbacks that alter plant defense phenotypes remain poorly understood. With a two-phase greenhouse bioassay, we investigated how leaf herbivory with Spodoptera exigua affects sunflower rhizosphere microbiome (Conditioning Phase) and whether herbivory-induced microbial shifts modulate plant defense traits via plant-soil feedback (Feedback Phase). Herbivory triggered significant changes in bacterial community structure and dynamics, as well as in microbiome functional profile, whereas effects on fungal community were weaker. Several bacterial taxa and functional groups were enriched, co-occurrence networks became more complex, and community assembly showed increased stochasticity. Herbivore-driven microbial legacies increased plant nutrient content and photosynthetic pigments via plant-soil feedback. After subsequent infestation, resistance-related traits and herbivore performance were unaffected, but tolerance-related traits were significantly altered. Plants grown with a herbivory-conditioned microbiome were smaller but exhibited reduced biomass loss after attack, indicating enhanced compensatory growth. Overall, herbivory reshaped the sunflower rhizosphere microbiome and generated a soil legacy that enhances plant tolerance, highlighting the role of microbiome-mediated plant-soil feedbacks in plant adaptation to herbivory.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Zheng Q, Thi Minh Nguyen T, Gwak YS, et al (2026)

Oral Lactiplantibacillus plantarum accelerates nucleotide excision repair and suppresses UVB-induced checkpoint immunosuppression.

NPJ biofilms and microbiomes, 12(1):.

Ultraviolet B (UVB) exposure initiates skin carcinogenesis by generating persistent DNA photolesions and immunosuppressive microenvironment. Whether a defined probiotic can reinforce genome maintenance while counteracting UVB-driven inflammatory-checkpoint programs remains unclear. Here we show that oral administration of Lactiplantibacillus plantarum TH-B59 accelerates cyclobutane pyrimidine dimers (CPDs) resolution and dampens γ-H2AX accumulation in UVB-irradiated BALB/c skin. TH-B59 restores the expression of nucleotide excision repair-related genes (Xpc, Ercc4, Xpa, and Ercc5) and attenuates UVB-induced PI3K/AKT signaling. In parallel, TH-B59 suppresses UVB-induced NF-κB/COX-2/PGE2 activation, reduces PD-L1 induction, and enhances IL-12 transcription, consistent with a shift toward immune surveillance. Fecal microbiota profiling identifies UVB-associated dysbiosis and a TH-B59-linked microbiome reconfiguration, with integrative correlation/network analyses connecting L. plantarum abundance to increased NER gene expression and reduced inflammatory mediators across gut and skin. Whole-genome sequencing supports TH-B59 as a bacteriocin-encoding, stress-tolerant strain lacking transferable antibiotic resistance and virulence determinants. Collectively, TH-B59 couples photolesion clearance with inflammatory-checkpoint remodeling to mitigate early UVB programs that drive photocarcinogenesis.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Kiyar M, Magaye R, Bailey S, et al (2026)

Tissue-specific metabolomics in experimental HFpEF reveals hepatic remodelling modulated by SGLT2 inhibition.

Cellular and molecular life sciences : CMLS, 83(1):.

BACKGROUND: Recent favourable clinical trials of sodium-glucose transporter 2 (SGLT2) inhibitors and glucagon-like-peptide-1 (GLP-1) agonists have substantially changed the management landscape for heart failure with preserved ejection fraction (HFpEF) patients. However, the organ-level metabolic mechanisms underpinning these benefits remain incompletely understood and it is unclear how these therapies reshape inter-organ metabolic crosstalk in HFpEF. In many patients, the HFpEF phenotype appears to result from an intersection between abnormal cardiovascular physiology together with metabolic and inflammatory changes.

METHODS: Experimental HFpEF was induced in 18-month-old female C57BL/6J mice with a high-fat diet for 12 weeks, an angiotensin II infusion beginning at week 6, with age-matched controls, to establish a cardiometabolic phenotype. Treatment with the SGLT2 inhibitor Dapagliflozin (Dapa) was administered for 6 weeks, concurrently with AngII administration. In addition to comprehensive cardiovascular and inflammatory phenotyping, we conducted metabolomic profiling of the heart, liver and plasma and performed 16S rRNA sequencing to characterise alterations in the gut microbiome.

RESULTS: Characteristic cardiometabolic and inflammatory profiles were observed in experimental HFpEF, including obesity, hypertension, diastolic dysfunction, hepatic steatosis, and gut dysbiosis. Despite no detectable improvement in echocardiographic function at endpoint, Dapa induced distinct hepatic remodelling, with increased citraconate, restoration of succinate, modulation of branched-chain amino acid and ketone pathways and reduced oxidative stress markers. Aromatic amino acid metabolism and gut-derived metabolites were broadly disrupted across heart, liver, and plasma.

CONCLUSION: HFpEF is defined by complex, tissue-specific metabolic derangements. SGLT2 inhibition primarily remodeled the hepatic metabolome, positioning the liver as a central hub of cardio-renal-liver crosstalk. These findings suggest that extra-cardiac metabolic pathways, particularly liver-centered mechanisms, may contribute to the therapeutic benefits of SGLT2 inhibitors in HFpEF and provide new insights into inter-organ metabolic regulation.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Dhar S, Paul S, Ahmed T, et al (2026)

The Human Microbiome, Dysbiosis, and Microbiome-Based Therapies.

Advances in experimental medicine and biology, 1513:1-30.

The human microbiome is a home to a broad spectrum of microorganisms that coexist with the host and are essential for sustaining good health by regulating energy metabolism, immune system and barrier functions. Basic physiological functions are maintained via a homeostatic microbiome while a dysbiotic microbiome is attributed to a wide range of disorders including metabolic, gastrointestinal, neurological, immunological disorders and certain types of cancer. Therefore, host-microbe interaction has become an important area of modern biomedical research.This chapter covers the framework and advancement of the human microbiome, major contributing factors in driving microbial communities and the mechanistic pathways by which microbes regulate host health. Dysbiosis-linked diseases and the developing prospect of microbiome-based therapeutic interventions are primarily emphasized in the chapter. From conventional methods like dietary modifications, prebiotics, probiotics, synbiotics and postbiotics to advanced personalized therapeutic strategies involving faecal microbiota transplantation, engineered microbial consortia and live biotherapeutics products for precise management of dysbiotic microbiomes are notably addressed.The importance of integrating conventional treatment methods with modern microbiome-based therapies is significantly highlighted in the chapter. These approaches work in a complementary manner to mitigate dysbiotic conditions, restore the microbial homeostasis, and reduce dysbiosis-related diseases. Target-specific microbiome-based therapy and microbiome-derived therapeutics are progressively developing contributing to evolutionize personalized and mechanism-specific treatment approaches and these strategies provide an intriguing pathway towards improving preventive and curative measures for overall well-being of host health.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Sikarwar MS, Siddiqui Z, VK Rathi (2026)

Probiotics, Prebiotics, Synbiotics and the Gut-Brain Axis in Precision Health.

Advances in experimental medicine and biology, 1513:41-89.

The gastrointestinal system synthesizes a considerable proportion of the body's neurotransmitters and neuromodulators and is consequently increasingly acknowledged as the "second brain." Advances in high-throughput sequencing technology following the Human Genome Project have considerably expanded understanding of the gut microbiome, igniting increasing interest in microbiota-based medicinal approaches. Probiotics, defined as live microorganisms offering health benefits when provided in suitable doses, have proven potential in the management of chronic inflammatory and immune-mediated illnesses through immunomodulatory and barrier-protective pathways. The therapeutic efficacy of probiotics is strain-specific and influenced by dosage, host physiology, and environmental factors; consequently, strain selection prioritizes functional attributes such as gastrointestinal survivability, adhesion to intestinal epithelium, modulation of resident microbiota, and antimicrobial activity. Despite promising clinical and preclinical evidence, comprehensive elucidation of the systemic effects of probiotics and identification of novel symbiotic strains remain critical research priorities, underscoring the need for interdisciplinary collaboration between pharmacologists and microbiologists.Another highly integral aspect of nutrition and medical research involves prebiotics. Prebiotics are defined as selectively fermentable substances that promote the activity and number of beneficial microbes in the gastrointestinal region. Oligosaccharides and inulin are examples that add to the betterment of metabolic homeostasis and immune system functioning. The rising consumer education and innovation have led to large-scale expansion in the prebiotics industry, which strengthens the connection between microbiology, nutrition, and health economics.Synbiotics that combine both probiotics and prebiotics represent a cutting-edge strategy that can enhance the resistance and stability of gut microbiota, especially in the gut-brain axis (GBA) microbiota network. New multiomics approaches have revealed the intricate relationships that exist between the microbiota and the host that modulate neuropathological, metabolic, and immunological outcomes. There is a great variation in the microbial populations and corresponding metabolic products among different human subjects that clearly reveals the need to develop microbiota-targeting therapies.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Arora M, Gaurav A, Chaudhary A, et al (2026)

Microbiome Modulation in Cancer Prevention, Personalized Nutrition, and Precision Medicine.

Advances in experimental medicine and biology, 1513:91-119.

Human microbiome which is a dynamic ecosystem of trillions of microorganisms is important in health and disease, especially in the establishment of cancer in ways such as through inflammation, generation of genotoxins, and immune modulation. This report aims to discuss the concept of microbiome modulation as a preventive and curative approach to cancer along with personalized nutrition and precision medicine. Dysbiosis is also associated with several types of cancers, such as colorectal, breast, and pancreatic whereby pathobionts, such as Fusobacterium nucleatum contribute to tumorigenesis, and beneficial taxa induce protective metabolites such as short-chain fatty acids. Eubiosis is restored through modulation methods such as probiotics, prebiotics, synbiotics, fecal microbiota transplantation, selective antibiotics, and dietary interventions and increase the efficacy of immunotherapy and decrease immunotherapy resistance. Anticancer properties of natural products, including curcumin, resveratrol, and berberine, can be summed up by their capacity to moderate microbiota in terms of achieving anti-inflammatory phenotypes. Gut microbes metabolically modify the food substances to produce bioactive metabolite, which affects the host immunity and epigenetics. Precision nutrition is a system that directs individuals to make diets based on multiomics data, microbiomics included, thereby predicting reactions and avoiding chronic diseases. Genome-scale reconstructions of metabolic models and machine learning computational models mimic these interactions to make personalized predictions. The problems are variability of microbiomes, standardization of data, ethical issues, and causality. In sum, this synthesis provides evidence that the microbiome can help make oncology a treatment centered on reaction to health issues but prevention based on individual needs and subjected to artificial intelligence personalization to allow administering the highest quality health to all the patients.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Basar N, Nath P, Das M, et al (2026)

Overview of In Silico Methods in Microbiome Studies.

Advances in experimental medicine and biology, 1513:121-131.

The recent advances in in-silico platforms have paved a way in rapid evolving of bioinformatics-based microbiome platforms such as multiomics techniques like amplicon sequencing or metagenomic, metatranscriptomics datasets. Advances in silico approach in such platforms have created vast datasets which provide effective relevant biological interpretations. This chapter provides a comprehensive overview of various computational software or packages applied for microbiome studies. Such frameworks highlight taxonomic profiling of microbial communities, microbes-host interaction, their functional annotations and disease relevance. Various established pipelines use machine learning and artificial intelligence algorithmic platforms which are discussed, putting an emphasizes on microbial profiling of samples, their comparative performance with preclinical/clinical evidences. Choice of relevant packages or collective pipelines significantly influence quantitative interpretation of microbiome datasets; the core biological inferences showed consistency yet increase in development of standard pipelines with precision is an unwaivable requirement for improving in silico dependent microbiome studies. The present study further explores applications and challenges of in silico platforms in relation to microbiome and their limited mechanistic studies. Future perspectives emphasize in development of microbial cloud-based pipelines, integrative multiomics and benchmarking in-silico platforms. Overall, this work highlights the present in silico platforms for microbiome studies of predictive modeling with mechanistic approach, shifting a focus towards an improved and better platforms from descriptive to predictive translational microbiome modeling.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Roy A, Gupta N, HK Prasad (2026)

Technological Frontiers in Microbiome Research: From Metagenomic Profiling to Functional and Spatial Characterization.

Advances in experimental medicine and biology, 1513:133-167.

The field of microbiome research is rapidly transitioning from descriptive taxonomic inventories to mechanistic systems biology, and the state-of-the-art technologies that enable this shift are summarized in this chapter, from short-read to third-generation long-read sequencing (PacBio HiFi, Oxford Nanopore), which now routinely assemble complete, circular genomes (MAGs), resolve genomic repeats and structural variants, and allow for detailed characterization of mobile genetic elements, which changes the way we think about microbial architecture. The chapter also discusses the emergence of holo-omics, the multi-layered analytical framework that combines metagenomics with metatranscriptomics (MET), metaproteomics (MEP), and metabolomics (MEB) to bridge the gap between genetic potential and realized phenotype, which brings its own challenges, primarily statistical challenges of data compositionality and dimensionality. To address these bottlenecks, the chapter reviews the renaissance of artificial intelligence (AI) in bioinformatics, including the application of deep learning models (COMEBin) for genome recovery and large language models for functional prediction. It also discusses the spatial and cellular frontiers of the field, where single-cell genomics and spatial metabolomics are mapping the detailed biogeography of host-microbe interactions at the micron scale. Finally, the chapter highlights that resolving the reproducibility crisis in the field is key to the clinical translation of these technologies, from rational microbiome engineering to personalized live biotherapeutics.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Uddin MJ, Sadiq SB, Snigdha NN, et al (2026)

Machine Learning Applications in Predicting Microbial Interactions.

Advances in experimental medicine and biology, 1513:169-212.

Health, the course of disease and treatment results are all significantly impacted by microbial interactions. However, it is challenging to examine the behaviour of microbial communities using conventional methods due to their complexity and diversity. A strong framework for identifying patterns in sizable and intricate biological datasets is provided by machine learning (ML). The use of machine learning (ML) to forecast microbial activity and comprehend how microbial populations react to drugs and other external factors is examined in this chapter. Microbiological data analysis has made extensive use of popular machine learning techniques like support vector machines, random forests and neural networks. These methods enable prediction of interspecies interactions, identification of metabolic interdependencies and classification of microbial taxa. ML models may also identify minute differences in microbial responses that affect treatment results by combining genomic, transcriptomic and metabolomic datasets. For instance, multi-omics integration can enhance predictions of microbial behaviour under stress through linking changes in gene expression with metabolite profiles. The chapter also covers how drug-induced dysbiosis, a disruption of the microbial balance brought on by medications, can be predicted using machine learning. ML techniques can identify possible changes in the composition of the microbiome and evaluate susceptibility to dysbiosis. The creation of therapeutic and preventative measures can be influenced by these forecasts. Together, these applications show how machine learning (ML) enhances drug-microbe interaction predictions, expands our knowledge of microbial dynamics and promotes precision medicine in microbiome and pharmaceutical research.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Uddin MJ, Dina AA, Khandaker S, et al (2026)

Multi-omics Integration for Microbiome Analysis.

Advances in experimental medicine and biology, 1513:213-250.

Multi-omics integration combines different omics datasets to reveal the complex and dynamic relationship between the host and its microbiome. Integrating such data remains challenging, as they contain high dimensionality, data heterogeneity, limited interpretability, insufficient standardization, and the use of different analytical approaches. It requires careful data collection, advanced computational analysis, and a systemic setting to interpret the complex biological information. Advances in next-generation sequencing (NGS) and microbial community profiling have enabled multi-omic investigations that include genomics, transcriptomics, metabolomics, and proteomics, providing a holistic understanding of these systems. Integrating these diverse data layers is essential for elucidating microbial functions and their impact on hosts and environments. The emerging holo-omics framework conceptualizes the host and its microbiome as a unified holobiont, providing a powerful perspective for studying mechanisms that maintain holobiont homeostasis. As multi-omics technologies advance, sophisticated statistical and computational methods are being developed to characterize biological variation and improve integrative analyses. Nonetheless, challenges remain, including data heterogeneity, methodological biases, and risks of false positives or negatives. This study aims to highlight the importance of integrating omics technologies like genomics, transcriptomics, proteomics, and metabolomics in generating comprehensive biological data and to gain a deeper insight into microbiome-host interactions. It also presents the current analytical and computational methods used and addresses major challenges for integrating multi-omics interactions. Recent work emphasizes strategies to reduce analytical errors and refine integration frameworks. Furthermore, innovations such as large language models offer promising tools for enhancing multi-omics interpretation, enabling more robust and comprehensive insights into host-microbiome systems.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Nahar L, Nath D, Talukdar AD, et al (2026)

Virtual Screening of Microbiome Modulators: Mechanisms, Computational Approaches, and Therapeutic Applications.

Advances in experimental medicine and biology, 1513:251-271.

The human gut microbiome regulates metabolism, immunity, and brain function through interactions between microbes and the host. Probiotics, prebiotics, synbiotics, and postbiotics reshape these communities to influence systemic health outcomes. These interventions address gut inflammation, obesity, infections, neurological disorders, and cancer. Virtual screening identifies compounds that target microbial or host-microbe pathways with high efficiently. This review describes modulator mechanisms with a focus on metabolic disorders, , diabetes, neurodegenerative diseases, and immune regulation. It highlights next-generation probiotics, precision probiotics, and microbiome‑derived therapeutic metabolites. This chapter presents microbiome-targeted therapies and future research directions enabled by through virtual screening.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Das SK, Sahariah B, MK Deka (2026)

Molecular Docking and Dynamics for Microbial Target Prediction.

Advances in experimental medicine and biology, 1513:273-279.

Predicting microbial targets is crucial for comprehending the mechanisms of various infectious diseases, which aids in the creation of novel medications by identifying biological components in microorganisms that can be targeted for intervention. To understand the mechanism, the microbial target prediction procedure mostly uses computational techniques (bioinformatics and machine learning) followed by experimental confirmation. In recent decades, the in silico approaches have attracted attention from microbial target prediction due to their potential to diminish high costs, low success rates, and extensive timelines of traditional microbial target prediction methods. This in silico process in microbial target prediction uses computational techniques to find possible targets for drug development by simulating drug-target interactions and forecasting biological behavior. These investigations use methods such as molecular docking to examine binding affinities between a drug candidate and a microbial target protein, subtractive genomics to identify critical microbial genes, and a variety of computational models to forecast a molecule's absorption, distribution, metabolism, excretion, and toxicity (ADMET). In silico approaches save money and time by reducing the number of possible targets and therapeutic candidates, however, experimental assays are still needed to validate the in silico results. Strong drug-protein binding does not, however, invariably result in the microorganism ceasing to develop or dying. These could be caused by a number of factors, including as the medicine not getting to the target inside the microbe, being digested or broken down, microbial resistance mechanisms, etc. Therefore considering the importance of in silico approaches in microbial target prediction, the usefulness of molecular docking and dynamics studies for microbial target prediction will be covered in this chapter, along with some recent developments in this area.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Kc BM, Koirala A, Rauniyar A, et al (2026)

Network Biology in Microbiome Modulation.

Advances in experimental medicine and biology, 1513:281-312.

Interactions between microbes and the host, together with the shared environments, form closely intertwined systems that can be studied as biological networks, which help us understand the underlying intricacies of such systems. Even still, the vast diversity and heterogeneity of these systems continue to make research involving their data a hassle. In this regard, over the past couple of decades, Network Biology has emerged as an efficient means of collection, analysis and interpretation of data obtained from such biological networks, especially microbial metabolic networks. Large databases and computational tools, along with publicly accessible online resources, have helped microbiome researchers integrate Network Biology and in silico approaches. Here, we introduce the fundamentals of a biological network, general methods of Network Biology, and means of mapping microbial networks for modulation of the microbiome. We also have explored databases for Network Biology studied such as PubMed, KEGG, MetaHIT, MiMeDB, Reactome, MGnify, BioCyc, along with open-source software tools, microbiome software, genomics software, evolutionary analysis software, sequencing methods, bioinformatics tools and online-available research tools applicable in microbiome modulation studies dependent on Network Biology principles. Lastly, we have discussed how these studies apply themselves in the health and medical sectors.

RevDate: 2026-11-18
CmpDate: 2026-11-18

Begum S, Mazumder PB, Das G, et al (2026)

AI-Based Tools for Predicting Gut Age Index and Health Status.

Advances in experimental medicine and biology, 1513:313-322.

The microbiota of the human gastrointestinal tract plays a vital role in overall well-being, influencing metabolic pathways, immune responses, and even brain function. Dysbiosis, disrupted microbial balance, is linked to disorders like IBD, obesity, and colorectal cancer. Conventional gut microbiome investigation approaches are limited by their restricted specificity, error, and failure to address functional diversity, as well as their reliance on gene-marker surveys, which often overlook rare microbes. Recent developments in artificial intelligence (AI) have significantly enhanced the accuracy of gut health diagnosis and prediction through the large-scale analysis of complex microbiome datasets, enabling the identification of patterns and connections that traditional statistical methods cannot. Tools including MiCoDe, GMWI2, CRCpred, DeepMicro, MicrobiomeAnalyst, GutBug, and QIIME 2 are built using AI methods, such as random forest modelling, Support Vector Machine (SVM), and network-based inference. These tools are revolutionising predictive gut microbiome analysis by allowing for early disease detection, risk evaluation, and personalised recommendations to therapies such as probiotics or dietary adjustments. Nonetheless, these developments in AI-based technologies encounter issues related to data standards, confidentiality, sample variety, and regional bias, which hinder the potential of these AI-driven tools in clinical practice. Further research on employing federated learning and the use of hybrid AI technologies can improve the transparency and reliability of these tools, since these tools can transform gut microbiome research into effective diagnostics and therapeutics for improving and optimising human gut health. This chapter explores the most recent advances in AI-powered approaches for predicting gut health, focusing on their procedures, effectiveness, and future medical implications.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Dalukdeniya DACK, RMUSK Rathnayaka (2026)

Systems Biology Models in Microbiome Therapeutics.

Advances in experimental medicine and biology, 1513:323-334.

Systems biology is an approach that integrates omics technologies such as genomics, transcriptomics, proteomics, metabolomics, and metagenomics with computational modelling tools for understanding complex biological systems. Systems biology approaches help to understand and capture dynamic interactions between microbial communities and the host, including metabolic cross-feeding, predicting emergent properties, and ecological relationships that influence host health and disease. This chapter reviews the use of different systems biology models used in microbiome therapeutics. The models include genome-scale metabolic models, ecological models, and multiscale simulations, which enable the prediction of microbial behaviour, their community dynamics, and host-microbe interactions. Large-scale studies such as the Human Microbiome Project, MetaHIT, and targeted dietary or probiotic interventional studies demonstrate how these integrated multi-omics and computational frameworks can facilitate the rational design of probiotics, engineered microbial consortia, and even lead to predicting personalized therapeutic strategies. Thus, the systems biology approach can be used in applications of drug discovery and precision medicine, including the prediction of drug-microbiome interactions, identification of microbial targets, and optimization of patient-specific interventions. Systems biology approaches, therefore, provide a platform for microbiome-informed therapeutics, supporting mechanistic insights, precision interventions, and accelerated translation from research to clinical application despite challenges such as individual variation and computational limitations.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Giri KR, Kothiwale N, Palandurkar K, et al (2026)

The Ethical and Regulatory Considerations in Microbiome-Based Research and Therapeutics.

Advances in experimental medicine and biology, 1513:335-349.

The human microbiome is transforming biomedical studies, clinical innovation, and the development of therapeutics. Gut microbiota is involved in vital activities of immunity, metabolism, nutrition, and homeostasis between the host and the microbe. Systems biology and sequencing technology have helped in the bench-to-bedside transformation of knowledge of microbiomes and their therapeutic applications, such as faecal microbiota transplantation (FMT), FDA-approved live biotherapeutic products (LBPs), engineered probiotics, and interventions designed by synthetic biology. Innovation also comes up with certain challenges like complicated ethical, regulatory, and governance dilemmas. Microbiome data have the potential to reveal personal information like lifestyle, health condition, and environmental exposure, which create privacy hazards. Reidentifications are also possible due to the complexity of the data. Scientific uncertainty and the long-term effects of the microbiome add to the complexity of informed consent. Donor selection, pathogen transmission, and adverse clinical events highlight why its regulation should be highly adaptive and strict. The international regulatory framework of microbiome-based treatments is not uniform. Manufacturing standards, quality-control requirements, and post-marketing surveillance systems require much attention. Global research cooperation and innovation are hampered because of these discrepancies, which also causes inequalities in patient access. Low- and middle-income countries (LMICs) such as India experience other challenges associated with capacity building of regulations and equal access to new therapies to every individual in the society. Microbiome data should be the representation of the whole population, not specific to any region; it becomes ethically challenging due to cultural diversity and data sovereignty. The application of artificial intelligence and sophisticated analytics to microbiome studies also brings some ethical issues of bias in algorithms, transparency, accountability, and fairness, especially when non-representative datasets are used to form the model. This chapter emphasizes that ethical microbiome therapeutics in clinical practice would necessitate proactive, coordinated, and global harmonized governance, but not reactive regulation. It is time to think and convert disjointed national strategies into an international harmonized regulatory frameworks that create an effective line on donor screening, manufacturing uniformity, analytical validation, safety checks, and assurance on quality. Simultaneously, the process of informed consent should be re-imagined as a dynamic and continuous involvement, openly discussing the possibility of risks over the long-term use, the use of secondary data, their biobanking, commercialization, and sharing of benefits, and capacity building in LMICs. To prevent harm to participant autonomy and trust, enhancing biobank governance is possible by enhancing clear policies regarding the ownership, access, reuse, and incidental findings. The systems of ethical oversight should also resolve the issues of conflicts of interest and commercial pressures. This chapter highlights that responsible human microbiome stewardship is the need of the hour. It is a mandatory activity to promote harmonized regulation, culturally sensitive ethical conduct, and policy creation based on equity. Such an ethically informed and globally coordinated course of action alone can see the full therapeutic potential of interventions based on microbiomes fulfilled at the same time as protecting individual rights, public trust, and common welfare.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Mandal A, Shome S, Sen S, et al (2026)

Translating Microbiome Research into Clinical Practice.

Advances in experimental medicine and biology, 1513:351-378.

The human microbiome can be defined as the collection of microorganisms living in and on the human body, and it plays an essential role in maintaining health and preventing disease. These microbial communities influence digestion, metabolism, immunity, and even brain function. When the balance of these microbes is disturbed, a condition called dysbiosis can occur, leading to various diseases such as inflammatory bowel disease (IBD), obesity, diabetes, allergies, and neurological disorders. Recent advances in high-throughput sequencing and bioinformatics have made it possible to study the composition and functions of the microbiome in greater detail. This knowledge has opened new opportunities for developing microbiome-based therapies, including probiotics, prebiotics, synbiotics, postbiotics, and microbiota transplantation. Among these, faecal microbiota transplantation (FMT) has shown remarkable success in treating recurrent Clostridioides difficile infections (rCDI). This chapter explores the journey of microbiome research from basic laboratory studies to clinical applications. It discusses key stages of the translational pathway, including discovery, preclinical models, clinical trials, regulatory challenges, and ethical considerations, highlighting the promise of microbiome science for future personalized and disease-preventive medicine.

RevDate: 2026-11-17
CmpDate: 2026-11-18

Das R, Das S, B Tamang (2026)

Future Direction in Gut Microbiome Modulation.

Advances in experimental medicine and biology, 1513:379-394.

The human gut microbiome has gradually moved from the margins of physiology to something much closer to the centre of the conversation. It shapes how food is broken down, helps train the immune system, nudges metabolic balance, and even appears to influence brain function, though exactly how remains open to debate. New tools, especially high-throughput sequencing, multi-omics workflows, and increasingly sophisticated computational models, have made it possible to look beyond who is there and begin asking what these microbes might be doing. Even so, working with human microbiomes is rarely straightforward. No two people carry the same microbial community, and small differences in diet, medication, or lifestyle can produce large shifts in composition and function. Add to that the lack of standardisation across studies, and it becomes difficult to draw firm causal links rather than correlations. Still, the associations keep accumulating. Altered microbial communities have been linked to conditions as varied as type 2 diabetes, colorectal cancer, neurodegenerative disorders, and chronic gut inflammation. These connections have naturally pushed interest towards ways of deliberately reshaping the gut ecosystem. Rather than treating microbiome modulation as a simple add-on, this chapter approaches it as a form of ecosystem management guided by precision data. Traditional strategies such as probiotics, prebiotics, and synbiotics are placed alongside newer ideas, including modulation driven by microbial metabolites, targeted mineral supplementation, engineered probiotic strains, synthetic microbial consortia, and even attempts to edit microbial communities in situ. The underlying argument is that these interventions make the most sense when paired with predictive metagenomic and metabolic models, which can help anticipate how a given microbiome might respond, or resist change altogether. That said, the path from concept to practice is not smooth. Long-term clinical evidence is still sparse, microbial engraftment remains unpredictable, and scaling personalised approaches beyond small cohorts poses obvious logistical challenges. Regulation is another unresolved piece of the puzzle, particularly when interventions blur the line between food, supplement, and therapy. There are also broader ecological questions. Introducing or reshaping microbial communities may have consequences that extend beyond individual patients. By keeping these constraints in view, the chapter aims to temper optimism with realism and to sketch a future in which precision microbiome interventions are developed carefully, tested rigorously, and applied where they are most likely to make a meaningful difference, especially for nutritionally vulnerable groups.

▼ ▼ LOAD NEXT 100 CITATIONS

RJR Experience and Expertise

Researcher

Robbins holds BS, MS, and PhD degrees in the life sciences. He served as a tenured faculty member in the Zoology and Biological Science departments at Michigan State University. He is currently exploring the intersection between genomics, microbial ecology, and biodiversity — an area that promises to transform our understanding of the biosphere.

Educator

Robbins has extensive experience in college-level education: At MSU he taught introductory biology, genetics, and population genetics. At JHU, he was an instructor for a special course on biological database design. At FHCRC, he team-taught a graduate-level course on the history of genetics. At Bellevue College he taught medical informatics.

Administrator

Robbins has been involved in science administration at both the federal and the institutional levels. At NSF he was a program officer for database activities in the life sciences, at DOE he was a program officer for information infrastructure in the human genome project. At the Fred Hutchinson Cancer Research Center, he served as a vice president for fifteen years.

Technologist

Robbins has been involved with information technology since writing his first Fortran program as a college student. At NSF he was the first program officer for database activities in the life sciences. At JHU he held an appointment in the CS department and served as director of the informatics core for the Genome Data Base. At the FHCRC he was VP for Information Technology.

Publisher

While still at Michigan State, Robbins started his first publishing venture, founding a small company that addressed the short-run publishing needs of instructors in very large undergraduate classes. For more than 20 years, Robbins has been operating The Electronic Scholarly Publishing Project, a web site dedicated to the digital publishing of critical works in science, especially classical genetics.

Speaker

Robbins is well-known for his speaking abilities and is often called upon to provide keynote or plenary addresses at international meetings. For example, in July, 2012, he gave a well-received keynote address at the Global Biodiversity Informatics Congress, sponsored by GBIF and held in Copenhagen. The slides from that talk can be seen HERE.

Facilitator

Robbins is a skilled meeting facilitator. He prefers a participatory approach, with part of the meeting involving dynamic breakout groups, created by the participants in real time: (1) individuals propose breakout groups; (2) everyone signs up for one (or more) groups; (3) the groups with the most interested parties then meet, with reports from each group presented and discussed in a subsequent plenary session.

Designer

Robbins has been engaged with photography and design since the 1960s, when he worked for a professional photography laboratory. He now prefers digital photography and tools for their precision and reproducibility. He designed his first web site more than 20 years ago and he personally designed and implemented this web site. He engages in graphic design as a hobby.

963 Red Tail Lane
Bellingham, WA 98226

206-300-3443

E-mail: RJR8222@gmail.com

Collection of publications by R J Robbins

Reprints and preprints of publications, slide presentations, instructional materials, and data compilations written or prepared by Robert Robbins. Most papers deal with computational biology, genome informatics, using information technology to support biomedical research, and related matters.

Research Gate page for R J Robbins

ResearchGate is a social networking site for scientists and researchers to share papers, ask and answer questions, and find collaborators. According to a study by Nature and an article in Times Higher Education , it is the largest academic social network in terms of active users.

Curriculum Vitae for R J Robbins

short personal version

Curriculum Vitae for R J Robbins

long standard version

RJR Picks from Around the Web (updated 11 MAY 2018 )